Docoh
Loading...

TRT Trio-Tech International

Filed: 11 Feb 21, 9:31am

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Quarterly Period Ended December 31, 2020
 
OR
 
☐    
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Transition Period from ___ to ___
 
Commission File Number 1-14523
 
TRIO-TECH INTERNATIONAL
(Exact name of Registrant as specified in its Charter)
 
California 95-2086631
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
   
Block 1008 Toa Payoh North  
Unit 03-09 Singapore 318996
(Address of principal executive offices) (Zip Code)
 
           Registrant's Telephone Number, Including Area Code:  (65) 6265 3300
 
Securities registered pursuant to Section 12(b) of the Act:
  Name of each exchange
Title of each classTrading SymbolOn which registered
Common Stock, no par valueTRT NYSE American
 
Securities registered pursuant to Section 12(g) of the Act: None
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes ☒ No ☐  
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ☒  No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non­accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b­2 of the Exchange Act. (Check one):
 
 Large Accelerated Filer
 
 Accelerated Filer
 Non-Accelerated Filer 
 
 Smaller reporting company 
   Emerging growth company
     
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒
 
As of February 1, 2021, there were 3,710,555 shares of the issuer’s Common Stock, no par value, outstanding.
 
 

 

 
 
TRIO-TECH INTERNATIONAL
 
INDEX TO CONDENSED CONSOLIDATED FINANCIAL INFORMATION, OTHER INFORMATION AND SIGNATURE
 
  Page
Part I.Financial Information 
   
2

2

3

5

6

7
32
47
47
   
Part II.Other Information 
   
48
48
48
48
48
48
48
  
49
 

 
 
FORWARD-LOOKING STATEMENTS
 
The discussions of Trio-Tech International’s (the “Company”) business and activities set forth in this Form 10-Q and in other past and future reports and announcements by the Company may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and assumptions regarding future activities and results of operations of the Company. In light of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, the following factors, among others, could cause actual results to differ materially from those reflected in any forward-looking statements made by or on behalf of the Company: market acceptance of Company products and services; changing business conditions or technologies and volatility in the semiconductor industry, which could affect demand for the Company’s products and services; the impact of competition; problems with technology; product development schedules; delivery schedules; changes in military or commercial testing specifications which could affect the market for the Company’s products and services; difficulties in profitably integrating acquired businesses, if any, into the Company; risks associated with conducting business internationally and especially in Asia, including currency fluctuations and devaluation, currency restrictions, local laws and restrictions and possible social, political and economic instability; changes in U.S. and global financial and equity markets, including market disruptions and significant interest rate fluctuations; public health issues related to the COVID-19 pandemic; the trade tension between U.S. and China; and other economic, financial and regulatory factors beyond the Company’s control. Other than statements of historical fact, all statements made in this Quarterly Report are forward-looking, including, but not limited to, statements regarding industry prospects, future results of operations or financial position, and statements of our intent, belief and current expectations about our strategic direction, prospective and future financial results and condition. In some cases, you can identify forward-looking statements by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “estimates,” “potential,” “believes,” “can impact,” “continue,” or the negative thereof or other comparable terminology. Forward-looking statements involve risks and uncertainties that are inherently difficult to predict, which could cause actual outcomes and results to differ materially from our expectations, forecasts and assumptions.
 
Unless otherwise required by law, we undertake no obligation to update forward-looking statements to reflect subsequent events, changed circumstances, or the occurrence of unanticipated events. You are cautioned not to place undue reliance on such forward-looking statements.
 
 
 
PART I. FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT NUMBER OF SHARES)
 
 
 
December 31,
2020
 
 
June 30,
2020
 
ASSETS
 
(Unaudited)
 
 
 
 
CURRENT ASSETS:
 
 
 
 
 
 
     Cash and cash equivalents
 $4,470 
 $4,150 
     Short-term deposits
  6,940 
  6,838 
     Trade accounts receivable, less allowance for doubtful accounts of $320 and $314,
     respectively
  7,581 
  5,951 
     Other receivables
  670 
  998 
     Inventories, less provision for obsolete inventories of $688 and $678, respectively
  2,147 
  1,922 
     Prepaid expenses and other current assets
  342 
  341 
 Total current assets
  22,150 
  20,200 
NON-CURRENT ASSETS:
    
    
     Deferred tax assets
  354 
  247 
     Investment properties, net
  712 
  690 
     Property, plant and equipment, net
  10,050 
  10,310 
     Operating lease right-of-use assets
  1,514 
  944 
     Other assets
  1,831 
  1,609 
     Restricted term deposits
  1,752 
  1,660 
          Total non-current assets
  16,213 
  15,460 
TOTAL ASSETS
 $38,363 
 $35,660 
 
    
    
LIABILITIES
    
    
CURRENT LIABILITIES:
    
    
     Lines of credit
 $- 
 $172 
     Accounts payable
  3,103 
  2,590 
     Accrued expenses
  3,395 
  3,005 
     Income taxes payable
  341 
  344 
     Current portion of bank loans payable
  443 
  370 
     Current portion of finance leases
  227 
  231 
     Current portion of operating leases
  562 
  477 
     Current portion of PPP loan
  121 
  54 
 Total current liabilities
  8,192 
  7,243 
NON-CURRENT LIABILITIES: 
    
    
     Bank loans payable, net of current portion
  1,899 
  1,836 
     Finance leases, net of current portion
  353 
  435 
     Operating leases, net of current portion
  952 
  467 
     Income taxes payable
  385 
  430 
     PPP loan, net of current portion
  - 
  67 
     Other non-current liabilities
  34 
  36 
           Total non-current liabilities
  3,623 
  3,271 
TOTAL LIABILITIES
 $11,815 
 $10,514 
 
    
    
EQUITY
    
    
TRIO-TECH INTERNATIONAL’S SHAREHOLDERS' EQUITY:
    
    
     Common stock, no par value, 15,000,000 shares authorized; 3,710,555 shares issued and outstanding as at December 31, 2020 and 3,673,055 shares as at June 30, 2020, respectively
 $11,525 
 $11,424 
     Paid-in capital
  3,378 
  3,363 
     Accumulated retained earnings
  8,263 
  8,036 
     Accumulated other comprehensive income-translation adjustments
  2,703 
  1,143 
 Total Trio-Tech International shareholders' equity
  25,869 
  23,966 
     Non-controlling interest
  679 
  1,180 
 TOTAL EQUITY
 $26,548 
 $25,146 
TOTAL LIABILITIES AND EQUITY
 $38,363 
 $35,660 
 
See notes to condensed consolidated financial statements 
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME / (LOSS)
UNAUDITED (IN THOUSANDS, EXCEPT EARNINGS PER SHARE)
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
 2020
 
 
2019
 
 
2020
 
 
2019
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
  Manufacturing
 $3,569 
 $3,045 
 $6,194 
 $6,362 
  Testing services
  3,560 
  3,887 
  6,514 
  8,277 
  Distribution
  1,065 
  2,014 
  2,323 
  4,113 
  Real estate
  7 
  16 
  11 
  33 
 
  8,201 
  8,962 
  15,042 
  18,785 
Cost of Sales
    
    
    
    
   Cost of manufactured products sold
  2,770 
  2,383 
  4,707 
  4,938 
   Cost of testing services rendered
  2,678 
  2,918 
  5,000 
  6,109 
   Cost of distribution
  861 
  1,738 
  1,908 
  3,545 
   Cost of real estate
  22 
  18 
  39 
  36 
 
  6,331 
  7,057 
  11,654 
  14,628 
 
    
    
    
    
Gross Margin
  1,870 
  1,905 
  3,388 
  4,157 
 
    
    
    
    
Operating Expenses:
    
    
    
    
  General and administrative
  1,662 
  1,777 
  3,322 
  3,565 
  Selling
  122 
  176 
  233 
  366 
  Research and development
  123 
  125 
  198 
  201 
 Gain on disposal of property, plant and equipment
  - 
  - 
  (1)
  (24)
           Total operating expenses
  1,907 
  2,078 
  3,752 
  4,108 
 
    
    
    
    
(Loss) / Income from Operations
 $(37)
 $(173)
 $(364)
 $49 
 
    
    
    
    
Other Income / (Expenses)
    
    
    
    
  Interest expenses
  (34)
  (55)
  (71)
  (123)
  Gain on sale of asset held for sale
  - 
  1,172 
  - 
  1,172 
  Other income, net
  143 
  40 
  354 
  150 
  Total other income / (expenses)
  109 
  1,157 
  283 
  1,199 
 
    
    
    
    
Income / (Loss) from Continuing Operations before Income Taxes
 $72 
 $984 
 $(81)
 $1,248 
 
    
    
    
    
Income Tax Expenses
  - 
  120 
  7 
  120 
 
    
    
    
    
Income / (loss) from continuing operations before non-controlling interest, net of tax
  72 
  864 
  (88)
  1,128 
 
    
    
    
    
Discontinued Operations
    
    
    
    
Income / (loss) from discontinued operations, net of tax
  (21)
  1 
  (27)
  - 
NET INCOME / (LOSS)
 $51 
 $865 
 $(115)
 $1,128 
 
    
    
    
    
Less: net (loss) / income attributable to non-controlling interest
  (184)
  439 
  (342)
  429 
Net Income Attributable to Trio-Tech International Common Shareholders
 $235 
 $426 
 $227 
 $699 
 
    
    
    
    
Amounts Attributable to Trio-Tech International Common Shareholders:
    
    
    
    
Income from continuing operations, net of tax
  246 
  425 
  241 
  699 
(Loss) / income from discontinued operations, net of tax
  (11)
  1 
  (14)
  - 
Net Income Attributable to Trio-Tech International Common Shareholders
 $235 
 $426 
 $227 
 $699 
 
    
    
    
    
Basic Earnings per Share:
    
    
    
    
Basic per share from continuing operations attributable to Trio-Tech International
 $0.06 
 $0.12 
 $0.06 
 $0.19 
Basic earnings per share from discontinued operations attributable to Trio-Tech International
  - 
  - 
  - 
  - 
Basic Earnings per Share from Net Income
    
    
    
    
Attributable to Trio-Tech International
 $0.06 
 $0.12 
 $0.06 
 $0.19 
 
    
    
    
    
Diluted Earnings per Share:
    
    
    
    
Diluted earnings per share from continuing operations attributable to Trio-Tech International
 $0.06 
 $0.11 
 $0.06 
 $0.19 
Diluted earnings per share from discontinued operations attributable to Trio-Tech International
 $- 
 $- 
 $- 
 $- 
Diluted Earnings per Share from Net Income
    
    
    
    
Attributable to Trio-Tech International
 $0.06 
 $0.11 
 $0.06 
 $0.19 
 
    
    
    
    
Weighted average number of common shares outstanding
    
    
    
    
Basic
  3,710 
  3,673 
  3,710 
  3,673 
Dilutive effect of stock options
  90 
  52 
  83 
  33 
Number of shares used to compute earnings per share diluted
  3,800 
  3,725 
  3,793 
  3,706 
 
See notes to condensed consolidated financial statements.
 
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME / (LOSS)
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Comprehensive Income Attributable to Trio-Tech International Common Shareholders: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income / (loss)
 $51 
 $865 
 $(115)
 $1,128 
Foreign currency translation, net of tax
  943 
  525 
  1,583 
  (38)
Comprehensive Income
  994 
  1,390 
  1,468 
  1,090 
Less: comprehensive (loss) / income attributable to non-controlling interest
  (197)
  431 
  (319)
  440 
Comprehensive Income Attributable to Trio-Tech International Common Shareholders
 $1,191 
 $959 
 $1,787 
 $650 
    
    
    
    
    
 
See notes to condensed consolidated financial statements.
 
 
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(IN THOUSANDS) 
 
Six months ended December 31, 2020
 
 
Common
Stock
 
 
 Paid-in
 
 
Accumulated Retained
 
 
Accumulated Other
Comprehensive
 
 
Non- controlling
 
 
 
 
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Earnings
 
 
Income
 
 
Interest
 
 
Total
 
 
 
 
 $
 
 $
 
 $
 
 $
 
 $
 
 $
 
Balance at June 30, 2020
  3,673 
  11,424 
  3,363 
  8,036 
  1,143 
  1,180 
  25,146 
Stock option expenses
  - 
  - 
  15 
  - 
  - 
  - 
  15 
Net income/ (loss)
  - 
  - 
  - 
  227 
  - 
  (342)
  (115)
Dividend declared by subsidiary
  - 
  - 
  - 
  - 
  - 
  (182)
  (182)
Exercise of stock option
  37 
  101 
  - 
  - 
  - 
  - 
  101 
Translation adjustment
  - 
  - 
  - 
  - 
  1,560 
  23 
  1,583 
Balance at Dec. 31, 2020
  3,710 
  11,525 
  3,378 
  8,263 
  2,703 
  679 
  26,548 
 
Six months ended December 31, 2019
 
 
Common
Stock
 
 
 Paid-in
 
 
Accumulated Retained
 
 
Accumulated Other
Comprehensive
 
 
Non- controlling
 
 
 
 
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Earnings
 
 
Income
 
 
Interest
 
 
Total
 
 
 
 
 $
 
 $
 
 $
 
 $
 
 $
 
 $
 
Balance at June 30, 2019
  3,673 
  11,424 
  3,305 
  7,070 
  1,867 
  1,195 
  24,861 
Stock option expenses
  - 
  - 
  14 
  - 
  - 
  - 
  14 
Net income
  - 
  - 
  - 
  699 
  - 
  429 
  1,128 
Dividend declared by subsidiary
  - 
  - 
  - 
  - 
  - 
  (120)
  (120)
Translation adjustment
  - 
  - 
  - 
  - 
  (49)
  11 
  (38)
Balance at Dec. 31, 2019
  3,673 
  11,424 
  3,319 
  7,769 
  1,818 
  1,515 
  25,845 
 
See notes to condensed consolidated financial statements.
 
 
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (IN THOUSANDS)
 
 
 
Six Months Ended
 
 
 
Dec. 31,
 
 
Dec. 31,
 
 
 
2020
 
 
2019
 
 
 
(Unaudited)
 
 
(Unaudited)
 
Cash Flow from Operating Activities
 
 
 
 
 
 
Net (loss) / income
 $(115)
 $1,128 
Adjustments to reconcile net income to net cash flow provided by operating activities
    
    
   Depreciation and amortization
  1,469 
  1,576 
   Stock compensation
  15 
  14 
   Addition / (reversal) of provision for obsolete inventories
  10
  (5)
   Bad debt (recovery) expenses
  (15)
  45 
   Accrued interest expense, net accrued interest income
  (18)
  (20)
   Payment of interest portion of finance lease
  (19)
  (24)
    Gain on sale of asset held for sale
  - 
  (1,172)
    Gain on sale of property, plant and equipment
  (1)
  (24)
   Dividend income
  (32)
  - 
   Dividend received
  32 
  - 
   Reversal of income tax provision
  55 
  - 
   Deferred tax benefit
  (83)
  (47)
Changes in operating assets and liabilities, net of acquisition effects
    
    
   Trade accounts receivable
  (1,595)
  132 
   Other receivables
  328 
  65 
   Other assets
  (86)
  97 
   Inventories
  (140)
  247 
   Prepaid expenses and other current assets
  (1)
  (43)
   Accounts payable and accrued expenses
  1,000 
  (6)
   Income taxes payable
  (114)
  (31)
   Operating lease liabilities
  (375)
  (359)
Net Cash Provided by Operating Activities
  315 
  1,573 
 
    
    
Cash Flow from Investing Activities
    
    
Proceeds from disposal of property, plant and equipment
  - 
  39 
Proceeds from sale of asset held for sale
  - 
  1,261 
Withdrawal of unrestricted deposit
  520 
  - 
Investment in unrestricted term deposits, net
  (409)
  (2,672)
Additions to property, plant and equipment
  (217)
  (744)
Net Cash Used in Investing Activities
  (106)
  (2,116)
 
    
    
Cash Flow from Financing Activities
    
    
Payment on lines of credit
  (174)
  (729)
Payment of bank loans
  (307)
  (245)
Payment of principal portion of finance leases
  - 
  (127)
Dividends paid on non-controlling interest
  (182)
  (120)
Proceeds from exercise stock options
  101 
  - 
Proceeds from lines of credit
  - 
  1,337 
Proceeds from bank loans
  205 
  - 
Proceeds from principal of finance leases
  - 
  279 
Net Cash (Used in)/ Provided by Financing Activities
  (357)
  395 
 
    
    
Effect of Changes in Exchange Rate
  560 
  38 
 
    
    
Net Increase/(Decrease) in Cash, Cash Equivalents, and Restricted Cash
  412 
  (110)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period
  5,810 
  6,569 
Cash, Cash Equivalents, and Restricted Cash at end of Period
 $6,222 
 $6,459 
 
    
    
Supplementary Information of Cash Flows
    
    
Cash paid during the period for:
    
    
Interest
 $71 
 $124 
Income taxes
 $114 
 $109 
 
    
    
Non-Cash Transactions
    
    
  Finance lease of property, plant and equipment
 $- 
 $279 
 
Reconciliation of Cash, Cash Equivalents, and Restricted Cash
 
 
 
 
 
 
Cash
 $4,470 
 $4,743 
Restricted Term-Deposits in Non-Current Assets
  1,752 
  1,716 
Total Cash, Cash Equivalents, and Restricted Cash Shown in the Statements of Cash Flows
 $6,222 
 $6,459 
 
                                             See notes to condensed consolidated financial statements.
 
Amounts included in restricted deposits represent the amount of cash pledged to secure loans payable or trade financing granted by financial institutions and serve as collateral for public utility agreements such as electricity and water, and performance bonds related to customs duty payable. Restricted deposits are classified as non-current assets as they relate to long-term obligations and will become unrestricted only upon discharge of the obligations.
 
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT EARNINGS PER SHARE AND NUMBER OF SHARES)
 
1. ORGANIZATION AND BASIS OF PRESENTATION
 
Trio-Tech International (“the Company” or “TTI” hereafter) was incorporated in fiscal year 1958 under the laws of the State of California. TTI provides third-party semiconductor testing and burn-in services primarily through its laboratories in Southeast Asia. In addition, TTI operates testing facilities in the United States. The Company also designs, develops, manufactures and markets a broad range of equipment and systems used in the manufacturing and testing of semiconductor devices and electronic components. In the second quarter of fiscal year 2021, TTI conducted business in four business segments: Manufacturing, Testing Services, Distribution and Real Estate. TTI has subsidiaries in the U.S., Singapore, Malaysia, Thailand, Indonesia and China as follows:
 
 
Ownership
Location
Express Test Corporation (Dormant)100%Van Nuys, California
Trio-Tech Reliability Services (Dormant)100%Van Nuys, California
KTS Incorporated, dba Universal Systems (Dormant)100%Van Nuys, California
European Electronic Test Centre (Dormant)100%Dublin, Ireland
Trio-Tech International Pte. Ltd.100%Singapore
Universal (Far East) Pte. Ltd.  *100%Singapore
Trio-Tech International (Thailand) Co. Ltd. *100%Bangkok, Thailand
Trio-Tech (Bangkok) Co. Ltd.100%Bangkok, Thailand
Trio-Tech (Malaysia) Sdn. Bhd.
(55% owned by Trio-Tech International Pte. Ltd.)
55%Penang and Selangor, Malaysia
Trio-Tech (Kuala Lumpur) Sdn. Bhd.55%Selangor, Malaysia
(100% owned by Trio-Tech Malaysia Sdn. Bhd.)  
Prestal Enterprise Sdn. Bhd.76%Selangor, Malaysia
(76% owned by Trio-Tech International Pte. Ltd.)  
Trio-Tech (SIP) Co., Ltd. *100%Suzhou, China
Trio-Tech (Chongqing) Co. Ltd. *100%Chongqing, China
SHI International Pte. Ltd. (Dormant)
(55% owned by Trio-Tech International Pte. Ltd)
55%Singapore
PT SHI Indonesia (Dormant)
(100% owned by SHI International Pte. Ltd.)
55%
 
Batam, Indonesia
 
Trio-Tech (Tianjin) Co., Ltd. *100%Tianjin, China
  * 100% owned by Trio-Tech International Pte. Ltd.
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. All significant inter-company accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements are presented in U.S. dollars. The accompanying condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. Operating results for the three and six months ended December 31, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2021. Certain accounting matters that generally require consideration of forecasted financial information were assessed regarding impacts from the COVID-19 pandemic as of December 31, 2020 and through the Quarterly Report dated February 11, 2021 using reasonably available information as of those dates. Those accounting matters assessed included, but were not limited to, allowance for doubtful accounts, the carrying value of long-lived tangible assets and the valuation allowances for tax assets. While the assessments resulted in no material impacts to the consolidated financial statements as of and for the quarter ended December 31, 2020, the Company believes the full impact of the pandemic remains uncertain and the Company will continue to assess if ongoing developments related to the pandemic may cause future material impacts to our consolidated financial statements. As of December 31, 2020, the Company had cash and cash equivalents and short-term deposits totalling $11,410 and unused lines of credit of $6,187. We finance operations primarily through our existing cash balances, cash collected from operations, bank borrowings and capital lease financing. We believe these sources are sufficient to fund our operations for the foreseeable future. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report for the fiscal year ended June 30, 2020.
 
The Company’s operating results are presented based on the translation of foreign currencies using the respective quarter’s average exchange rate.

 
Basis of Presentation and Summary of Significant Accounting Policies
 
Leases-Lessee
 
Accounting Standards Codification ("ASC") Topic 842 introduces new requirements to increase transparency and comparability among organizations for leasing transactions for both lessees and lessors. It requires a lessee to record a right-of-use asset and a lease liability for all leases with terms longer than 12 months. These leases will be either finance or operating, with classification affecting the pattern of expense recognition.
 
The standard provided an alternative modified retrospective transition method. Under this method, the cumulative effect adjustment to the opening balance of retained earnings is recognized on the date of adoption (July 1, 2019). The Company adopted ASC 842 as of July 1, 2019, and applied the alternative modified retrospective transition method requiring application of the new guidance to all leases existing at, or entered into on or after, the date of adoption i.e., July 1, 2019.
 
The Company applies the guidance in ASC 842 to individual leases of assets. When the Company receives substantially all the economic benefits from and directs the use of specified property, plant and equipment, transactions give rise to leases. The Company’s classes of assets include real estate leases.
 
Operating leases are included in operating lease right-of-use ("ROU") assets, current portion and long-term portion of operating leases in our consolidated balance sheets. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Finance leases are included in plant and equipment, current portion and long-term portion of finance leases in our consolidated balance sheets.
 
The Company has elected the practical expedient within ASC 842 to not separate lease and non-lease components within lease transactions for all classes of assets. Additionally, the Company has elected the short-term lease exception for all classes of assets, does not apply the recognition requirements for leases of 12 months or less, and recognizes lease payments for short-term leases as expense either straight-line over the lease term or as incurred depending on whether the lease payments are fixed or variable. These elections are applied consistently for all leases.
 
As part of applying the transition method, the Company has elected to apply the package of transition practical expedients within the new guidance. As required by the new standard, these expedients have been elected as a package and are consistently applied across the Company’s lease portfolio. Given this election, the Company need not reassess:
 
whether any expired or existing contracts are or contain leases;
the lease classification for any expired or existing leases;
treatment of initial direct costs relating to any existing leases.
 
When discount rates implicit in leases cannot be readily determined, the Company uses the applicable incremental borrowing rate at lease commencement to perform lease classification tests on lease components and to measure lease liabilities and ROU assets. The incremental borrowing rate used by the Company was based on baseline rates and adjusted by the credit spreads commensurate with the Company’s secured borrowing rate over a similar term. At each reporting period when there is a new lease initiated, the rates established for that quarter will be used.
 
In applying the alternative modified retrospective transition method, the Company measured lease liabilities at the present value of the sum of remaining minimum rental payments (as defined under ASC Topic 840). The present value of lease liabilities has been measured using the Company’s incremental borrowing rates as of July 1, 2019 (the date of initial application). Additionally, ROU assets for these operating leases have been measured as the initial measurement of application lease liabilities adjusted for reinstatement liabilities.
 
Leases-Lessor
 
For the Company as lessor, all our leases will continue to be classified as operating leases under the new standard. We do not expect the new standard to have a material effect on our financial statements and we do not expect a significant change in our leasing activities between now and adoption.
  
 
2.    NEW ACCOUNTING PRONOUNCEMENTS
 
In October 2020, FASB issued ASU2020-10: Codification Improvements. This update contains amendments that improve the consistency of the Codification by including all disclosure guidance in the appropriate Disclosure Section (Section 50). Many of the amendments arose because the Board provided an option to give certain information either on the face of the financial statements or in the notes to financial statements and that option only was included in the Other Presentation Matters Section (Section 45) of the Codification. The option to disclose information in the notes to financial statements should have been codified in the Disclosure Section as well as the Other Presentation Matters Section (or other Section of the Codification in which the option to disclose in the notes to financial statements appears). The amendments in this update do not change GAAP and, therefore, are not expected to result in a significant change in practice. The amendments are effective for the Company for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. Adoption shall be applied retrospectively. The Company is currently evaluating the impacts of the provisions of ASU 2020-10 on its consolidated financial statements and related disclosures.
 
In August 2020, the FASB issued ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). This ASU reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusion. In addition, this ASU improves and amends the related EPS guidance. These amendments are effective for the Company for fiscal years beginning after December 15, 2023, including interim period within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company is currently evaluating the impacts of the provisions of ASU 2020-06 on its consolidated financial statements and related disclosures.
 
In December 2019, FASB issued ASU 2019-12 ASC Topic 740: Income Taxes: Simplifying Accounting for Income Taxes remove specific exceptions to the general principles in topic 740 in US GAAP. The amendments eliminate the need for an organization to analyze whether the specific exceptions apply in a given period, improve financial statement preparers’ application of income tax related guidance and simplify GAAP. The amendments are effective for all entities for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company is currently evaluating the impacts of the provisions of ASU 2019-12 on its consolidated financial statements and related disclosures.
 
In March 2020, FASB issued ASU 2020-04 ASC Topic 848: Reference Rate Reform: Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued. The amendments are effective for all entities as of March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. The Company is currently evaluating the impacts of the provisions of ASU 2020-04 on its consolidated financial statements and related disclosures.
 
In June 2016, FASB issued ASU 2016-13 ASC Topic 326: Financial Instruments — Credit Losses (“ASC Topic 326”) for the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. ASC Topic 326 is effective for the Company for annual periods beginning after December 15, 2022. The Company is currently evaluating the potential impact of this accounting standard update on its consolidated financial statements.
 
Other new pronouncements issued but not yet effective until after December 31, 2020 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations.
 
 
3.   TERM DEPOSITS
 
 
 
Dec. 31,
 2020
(Unaudited)
 
 
June 30,
 2020
 
 
 
 
 
 
 
 
Short-term deposits
 $6,723 
 $7,028 
Currency translation effect on short-term deposits
  217 
  (190)
Total short-term deposits
  6,940 
  6,838 
Restricted term deposits
  1,664 
  1,712 
Currency translation effect on restricted term deposits
  88 
  (52)
Total restricted term deposits
  1,752 
  1,660 
Total term deposits
 $8,692 
 $8,498 
 
Restricted deposits represent the amount of cash pledged to secure loans payable to financial institutions and serve as collateral for public utility agreements such as electricity and water, and performance bonds related to customs duty payable. Restricted deposits are classified as non-current assets, as they relate to long-term obligations and will become unrestricted only upon discharge of the obligations. Short-term deposits represent bank deposits, which do not qualify as cash equivalents.
 
4.   TRADE ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
 
Accounts receivable are customer obligations due under normal trade terms. The Company performs continuing credit evaluations of its customers’ financial conditions, and although management generally does not require collateral, letters of credit may be required from the customers in certain circumstances.
 
Senior management reviews accounts receivable on a periodic basis to determine if any receivables will potentially be uncollectible. Management includes any accounts receivable balances that are determined to be uncollectible in the allowance for doubtful accounts. After all reasonable attempts to collect a receivable have failed, the receivable is written off against the allowance. Based on the information available, management believed the allowance for doubtful accounts as of December 31, 2020 and June 30, 2020 was adequate.  
 
The following table represents the changes in the allowance for doubtful accounts: 
 
 
Dec. 31,
 2020
(Unaudited)
 
 
June 30,
 2020
 
Beginning
 $314 
 $263 
Additions charged to expenses
  - 
  351 
Recovered
  (15)
  (284)
Write-off
  - 
  (9)
Currency translation effect
  21 
  (7)
Ending
 $320 
 $314 
 
 
 
5.   LOANS RECEIVABLE FROM PROPERTY DEVELOPMENT PROJECTS
 
The following table presents Trio-Tech (Chongqing) Co. Ltd (“TTCQ”)’s loan receivable from property development projects in China as of December 31, 2020.
 
 
Loan Expiry
Date
 
Loan Amount
(RMB)
  
Loan Amount
(U.S. Dollars)
 
Short-term loan receivables       
JiangHuai (Project – Yu Jin Jiang An)May 31, 2013  2,000   307 
Less: allowance for doubtful receivables   (2,000)  (307)
Net loan receivables from property development projects   -   - 
          
Long-term loan receivables         
Jun Zhou Zhi YeOct 31, 2016  5,000   767 
Less: transfer – down-payment for purchase of investment property   (5,000)  (767)
Net loan receivables from property development projects   -   - 
 
The short-term loan receivables amounting to renminbi (“RMB”) 2,000, or approximately $307 arose due to TTCQ entering into a Memorandum Agreement with JiangHuai Property Development Co. Ltd. (“JiangHuai”) to invest in their property development projects (Project - Yu Jin Jiang An) located in Chongqing City, China in fiscal 2011. Based on TTI’s financial policy, a provision for doubtful receivables of $294 on the investment in JiangHuai was recorded during fiscal 2014. TTCQ did not generate other income from JiangHuai for the quarter ended December 31, 2020 or for the fiscal year ended June 30, 2020. TTCQ is in the legal process of recovering the outstanding amount of approximately $307.
 
The loan amounting to RMB 5,000, or approximately $767, arose due to TTCQ entering into a Memorandum Agreement with JiaSheng Property Development Co. Ltd. (“JiaSheng”) to invest in their property development projects (Project B-48 Phase 2) located in Chongqing City, China in fiscal 2011. The amount was unsecured and repayable at the end of the term. The book value of the loan receivable approximates its fair value. During fiscal year 2015, the loan receivable was transferred to down payment for purchase of investment property that is being developed in the Singapore Themed Resort Project (See Note 8).
  
 6.  INVENTORIES
 
 Inventories consisted of the following:
 
 
Dec. 31,
 2020
 (Unaudited)
 
 
June 30,
 2020
 
 
 
 
 
 
 
 
Raw materials
 $1,153 
 $1,281 
Work in progress
  1,304 
  968 
Finished goods
  282 
  422 
Currency translation effect
  96 
  (71)
Less: provision for obsolete inventories
  (688)
  (678)
 
 $2,147 
 $1,922 
 
The following table represents the changes in provision for obsolete inventories:
 
 
Dec. 31,
 2020
(Unaudited)
 
 
June 30,
 2020
 
 
 
 
 
 
 
 
Beginning
 $678 
 $673 
Additions charged to expenses
  10 
  26 
Usage – disposition
  (23)
  (8)
Currency translation effect
  23 
  (13)
Ending
 $688 
 $678 
 
 
 
7.   INVESTMENT PROPERTIES
 
The following table presents the Company’s investment in properties in China as of December 31, 2020. The exchange rate is based on the market rate as of December 31, 2020.
 
 
Investment Date /
Reclassification Date
 
Investment
Amount 
(RMB)
 
 
Investment
Amount
(U.S. Dollars)
 
Purchase of rental property – Property I – MaoYe PropertyJan 04, 2008
  5,554 
  894 
Currency translation 
  - 
  (87)
Reclassification as “Assets held for sale”July 01, 2019
  (5,554)
  (807)
Reclassification from “Assets held for sale”Mar 31, 2020
  2,024 
  301 
 
  2,024 
  301 
Purchase of rental property – Property II - JiangHuaiJan 06, 2010
  3,600 
  580 
Purchase of rental property – Property III - Fu LiApr 08, 2010
  4,025 
  648 
Currency translation 
  - 
  (50)
Gross investment in rental property 
  9,649 
  1,479 
Accumulated depreciation on rental propertySep 30, 2020
  (6,799)
  (1,034)
Reclassified as “Assets held for sale”- Mao Ye PropertyJuly 01, 2019
  2,822 
  410 
Reclassification from “Assets held for sale”- Mao Ye PropertyMar 31, 2020
  (1,029)
  (143)
 
  (5,006)
  (767)
Net investment in property – China 
  4,643 
  712 
 
The following table presents the Company’s investment in properties in China as of June 30, 2020. The exchange rate is based on the market rate as of June 30, 2020.
 
 
Investment Date /
Reclassification Date
 
Investment
Amount 
(RMB)
 
 
Investment
Amount
(U.S. Dollars)
 
Purchase of rental property – Property I – MaoYe PropertyJan 04, 2008
  5,554 
  894 
Currency translation 
  - 
  (87)
Reclassification as “Assets held for sale”July 01, 2019
  (5,554)
  (807)
Reclassification from “Assets held for sale”Mar 31, 2020
  2,024 
  301 
 
  2,024 
  301 
Purchase of rental property – Property II - JiangHuaiJan 06, 2010
  3,600 
  580 
Purchase of rental property – Property III - Fu LiApr 08, 2010
  4,025 
  648 
Currency translation 
  - 
  (166)
Gross investment in rental property 
  9,649 
  1,363 
Accumulated depreciation on rental propertyJune 30, 2020
  (6,558)
  (940)
Reclassified as “Assets held for sale”-Mao Ye PropertyJuly 01, 2019
  2,822 
  410 
Reclassification from “Assets held for sale”- Mao Ye PropertyMar 31, 2020
  (1,029)
  (143)
 
  (4,765)
  (673)
Net investment in property – China 
  4,884 
  690 
 
 
 
Rental Property I - Mao Ye Property
 
In fiscal 2008, TTCQ purchased an office in Chongqing, China from MaoYe Property Ltd. (“MaoYe”), for a total cash purchase price of RMB 5,554, or approximately $894.
 
Property purchased from MaoYe generated a rental income of $nil and $3 during the three and six months ended December 31, 2020 as compared to $8 and $16 for the same periods, respectively, in last fiscal year.
 
Depreciation expense for MaoYe was $4 and $8 for the three and six months ended December 31, 2020 and 2019, respectively.
 
Rental Property II - JiangHuai
 
In fiscal year 2010, TTCQ purchased eight units of commercial property in Chongqing, China from Chongqing JiangHuai Real Estate Development Co. Ltd. (“JiangHuai”) for a total purchase price of RMB 3,600, or approximately $580. TTCQ has yet to receive the title deed for these properties. TTCQ was in the legal process of obtaining the title deed until the developer encountered cash flow difficulties in recent years. Since fiscal year 2018, JiangHuai has been under liquidation and is now undergoing asset distribution. Nonetheless, this is not expected to affect the property’s market value but, in view of the COVID-19 pandemic and current economic situation, it is likely to be more tedious and time-consuming for the Court in their execution of the sale.
 
Property purchased from JiangHuai did not generate any rental income for the three and six months ended December 31, 2020 and 2019.
 
Depreciation expense for JiangHuai was $7 and $13 for the three and six months ended December 31, 2020 as compared to $7 and $14 for the same period in last fiscal year.
 
Rental Property III – FuLi
 
In fiscal 2010, TTCQ entered into a Memorandum Agreement with Chongqing FuLi Real Estate Development Co. Ltd. (“FuLi”) to purchase two commercial properties totaling 311.99 square meters (“office space”) located in Jiang Bei District Chongqing. The total purchase price committed and paid was RMB 4,025, or approximately $648. The development was completed, the property was handed over to TTCQ in April 2013 and the title deed was received during the third quarter of fiscal 2014.
 
One of the two commercial properties was leased by TTCQ to a third party under a lease providing for a rent increase of 6% every year on May 1, commencing in 2019 until the rental agreement expires on April 30, 2021. The agreement was terminated in April 2020 due to the current slow and cautious market rental conditions. Management is still actively looking for a tenant for this property.
 
For the other leased property, TTCQ renewed the lease agreement to rent out the 161 square meter space at a monthly rate of RMB10, or approximately $1, from November 1, 2019 to October 31, 2020.
 
Properties purchased from Fu Li generated a rental income of $4 and $7 for the three and six months ended December 31, 2020 as compared to $8 and $17 for the same period in the last fiscal year.
 
Depreciation expense for Fu Li was $7 and $14 for the three and six months ended December 31, 2020 and 2019, respectively as compared to $6 and $12 for the same period in the last fiscal year.
 
Summary
 
Total rental income for all investment properties in China was $7 and $11 for the three and six months ended December 31, 2020 as compared to $16 and $33 for the same periods, respectively, in the last fiscal year.
 
Depreciation expenses for all investment properties in China were $18 and $35 for the three and six months ended December 31, 2020, respectively, as compared to $17 and $34 same periods, respectively, in the last fiscal year.
  

 
8.   OTHER ASSETS
 
Other assets consisted of the following:
 
 
Dec. 31, 2020
(Unaudited)
 
 
June 30,
2020
 
Down payment for purchase of investment properties *
 $1,645 
 $1,645 
Down payment for purchase of property, plant and equipment
  144 
  8 
Deposits for rental and utilities
  122 
  171 
Currency translation effect
  (80)
  (215)
Total
 $1,831 
 $1,609 
 
*  Down payment for purchase of investment properties included:
 
 
 
RMB
 
 
US Dollars
 
Original Investment (10% of Jun Zhou equity)
  10,000 
  1,606 
Less: Management Fee
  (5,000)
  (803)
Net Investment
  5,000 
  803 
Less: Share of Loss on Joint Venture
  (137)
  (22)
Net Investment as Down Payment(Note *a)
  4,863 
  781 
Loans Receivable
  5,000 
  814 
Interest Receivable
  1,250 
  200 
Less: Impairment of Interest
  (906)
  (150)
Transferred to Down Payment(Note *b)
  5,344 
  864 

  10,207 
  1,645 
 *  Down Payment for Purchase of Investment Properties
 
a) On December 2, 2010, the Company signed a Joint Venture agreement (“agreement”) with Jia Sheng Property Development Co. Ltd. (“Developer”) to form a new company, Jun Zhou Co., Limited (“Joint Venture” or “Jun Zhou”) to joint develop the “Singapore Themed Park” project (the “project”), where the Company paid RMB 10 million for the 10% investment in the joint venture. The Developer paid the Company a management fee of RMB5 million in cash upon signing of the agreement with a remaining fee of RMB5 million payable upon fulfilment of certain conditions in accordance with the agreement. The Company further reduced its investment by RMB 137, or approximately $22, towards the losses from operations incurred by the joint venture.
 
On October 2, 2013, the Company disposed of its entire 10% interest in the joint venture. The Company recognized the disposal of its 10% investment in Jun Zhou based on the recorded net book value of RMB5 million or equivalent to US $803K, from net considerations paid, in accordance with US GAAP under ASC Topic 845 Non-monetary Consideration, and it’s presented under “Other Assets” as non-current assets to defer the recognition of the gain on the disposal of the 10% interest in joint venture investment until such time that the consideration is paid, so that the gain can be ascertained.
 
b) Amounts of RMB 5,000, or approximately $767, as disclosed in Note 5, plus the interest receivable on long term loan receivable of RMB 1,250, or approximately $200, and impairment on interest of RMB 906, or approximately $150.
 
The shop lots are to be delivered to TTCQ upon completion of the construction of the shop lots in Singapore Themed Resort Project. The initial targeted date of completion was December 31, 2016. Based on discussion with the developers, the completion date is currently estimated to be December 31, 2022. The delay was primarily due to the time needed by the developers to work with various parties to inject sufficient funds into this project.
  

 
9. LINES OF CREDIT
 
Carrying value of the Company’s lines of credit approximates its fair value because the interest rates associated with the lines of credit are adjustable in accordance with market situations when the Company borrowed funds with similar terms and remaining maturities.
 
The Company’s credit rating provides it with readily and adequate access to funds in global markets.
 
As of December 31, 2020, the Company had certain lines of credit that are collateralized by restricted deposits.
    
Entity withType ofInterest
 
Expiration
 
 
Credit
 
 
Unused
 
 Facility 
 Facility 
 Rate 
 
Date
 
 
Limitation
 
 
Credit
 






Trio-Tech International Pte. Ltd., Singapore 
Lines of Credit
Ranging from 1.85% to 5.5%,
SIBOR rate +1.25%
and LIBOR rate +1.30%
  - 
 $5,438 
 $5,438 
Trio-Tech International Pte. Ltd., Singapore  Lines of Credit  Ranging from 1.85% to 5.5%
  - 
 $378  
 $378  
 Trio-Tech Malaysia Sdn. Bhd.
Revolving Credit
   Cost of Funds Rate +2% 
  - 
 $371  
 $371  
  
As of June 30, 2020, the Company had certain lines of credit that are collateralized by restricted deposits.
 
Entity withType ofInterest
 
Expiration
 
 
Credit
 
 
Unused
 
 Facility 
 Facility 
 Rate 
 
Date
 
 
Limitation
 
 
Credit
 






Trio-Tech International Pte. Ltd., Singapore
Lines of Credit
Ranging from 1.85% to 5.5%,
SIBOR rate +1.25%
and LIBOR rate +1.30%
  - 
 $4,806 
 $4,806 
Universal (Far East) Pte. Ltd.
Lines of Credit
Ranging from 1.85% to 5.5%
  - 
 $359 
 $187 
Trio-Tech Malaysia Sdn. Bhd.
Revolving Credit
Cost of Funds Rate +2%
  - 
 $350 
 $350 
 
 
10.  ACCRUED EXPENSES
 
Accrued expenses consisted of the following:
 
 
Dec. 30,
 2020
(Unaudited)
 
 
June 30,
 2020
 
Payroll and related costs
 $1,118 
 $1,185 
Commissions
  84 
  104 
Customer deposits
  43 
  30 
Legal and audit
  230 
  315 
Sales tax
  13 
  19 
Utilities
  84 
  80 
Warranty
  11 
  12 
Accrued purchase of materials and property, plant and equipment
  727 
  186 
Provision for re-instatement
  376 
  300 
Deferred income
  85 
  88 
Contract liabilities
  579 
  476 
Other accrued expenses
  141 
  287 
Currency translation effect
  (96)
  (77)
Total
 $3,395 
 $3,005 
 
 
 
11.   WARRANTY ACCRUAL
 
The Company provides for the estimated costs that may be incurred under its warranty program at the time the sale is recorded.  The warranty period of the products manufactured by the Company is generally one year or the warranty period agreed with the customer.  The Company estimates the warranty costs based on the historical rates of warranty returns. The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amounts as necessary.
 
 
 
Dec. 30,
 2020
(Unaudited)
 
 
June 30,
 2020
 
Beginning
 $12 
 $39 
Additions charged to cost and expenses
  1 
  1 
Reversal
  (2)
  (27)
Currency translation effect
  - 
  (1)
Ending
 $11 
 $12 
 
12.   BANK LOANS PAYABLE
 
 Bank loans payable consisted of the following:
 
 
Dec. 31, 2020
(Unaudited)
 
 
June 30, 2020
 
Note payable denominated in RM for expansion plans in Malaysia, maturing in August 2028, bearing interest at the bank’s prime rate less 2.00% (3.85% at December 31, 2020 and June 30, 2020, respectively) per annum, with monthly payments of principal plus interest through August 2028, collateralized by the acquired building with a carrying value of $2,982 and $2,543, as at December 31, 2020 and June 30, 2020, respectively.
 $2,015 
 $2,295 
Financing arrangement at fixed interest rate 3.2% per annum, with monthly payments of principal plus interest through July 2025.
  190 
  - 
      Total bank loans payable
 $2,205 
 $2,295 
 
Current portion of bank loans payable
 $418 
 $384 
Currency translation effect on current portion of bank loans
  25 
  (14)
                              Current portion of bank loans payable
  443 
  370 
Long-term portion of bank loans payable
  1,787 
  1,911 
Currency translation effect on long-term portion of bank loans
  112 
  (75)
                           Long-term portion of bank loans payable
 $1,899 
 $1,836 
 
Future minimum payments (excluding interest) as at December 31, 2020 were as follows: 
 
Remainder of fiscal 2021
 $443 
2022
  460 
2023
  478 
2024
  341 
2025
  197 
Thereafter
  423 
Total obligations and commitments
 $2,342 
 
Future minimum payments (excluding interest) as at June 30, 2020 were as follows: 
 
2021
 $370 
2022
  384 
2023
  400 
2024
  403 
2025
  158 
Thereafter
  491 
Total obligations and commitments
 $2,206 
 
 
13.   COMMITMENTS AND CONTINGENCIES
 
The Company had capital commitments in China for the purchase of equipment and other related infrastructure costs amounting to RMB 1,856, or approximately $277 as at December 31, 2020, as compared to no capital commitment as at June 30, 2020.
 
Deposits with banks in China are not insured by the local government or agency, and are consequently exposed to risk of loss. The Company believes the probability of a bank failure, causing loss to the Company, is remote.
 
The Company is, from time to time, the subject of litigation claims and assessments arising out of matters occurring in its normal business operations. In the opinion of management, resolution of these matters will not have a material adverse effect on the Company’s financial statements.
 
14.   BUSINESS SEGMENTS
 
The Company generates revenue primarily from 3 different segments: Manufacturing, Testing and Distribution. The Company accounts for a contract with a customer when there is approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company’s revenues are measured based on consideration stipulated in the arrangement with each customer, net of any sales incentives and amounts collected on behalf of third parties, such as sales taxes. The revenues are recognized as separate performance obligations that are satisfied by transferring control of the product or service to the customer.
 
The revenue allocated to individual countries was based on where the customers were located. The allocation of the cost of equipment, the current year investment in new equipment and depreciation expense have been made based on the primary purpose for which the equipment was acquired.
 
Significant Judgments
 
The Company’s arrangements with its customers include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. A product or service is considered distinct if it is separately identifiable from other deliverables in the arrangement and if a customer can benefit from it on its own or with other resources that are readily available to the customer.
 
The Company allocates the transaction price to each performance obligation on a relative standalone selling price basis (“SSP”). Determining the SSP for each distinct performance obligation and allocation of consideration from an arrangement to the individual performance obligations and the appropriate timing of revenue recognition are significant judgments with respect to these arrangements. The Company typically establishes the SSP based on observable prices of products or services sold separately in comparable circumstances to similar clients. The Company may estimate SSP by considering internal costs, profit objectives and pricing practices in certain circumstances.
 
Warranties, discounts and allowances are estimated using historical and recent data trends. The Company includes estimates in the transaction price only to the extent that a significant reversal of revenue is not probable in subsequent periods. The Company’s products and services are generally not sold with a right of return, nor has the Company experienced significant returns from or refunds to its customers.
 
Manufacturing
 
The Company primarily derives revenue from the sale of both front-end and back-end semiconductor test equipment and related peripherals, maintenance and support of all these products, installation and training services and the sale of spare parts. The Company’s revenues are measured based on consideration stipulated in the arrangement with each customer, net of any sales incentives and amounts collected on behalf of third parties, such as sales taxes.
 
 
 
The Company recognizes revenue at a point in time when the Company has satisfied its performance obligation by transferring control of the product to the customer. The Company uses judgment to evaluate whether the control has transferred by considering several indicators, including:
 
whether the Company has a present right to payment;
 
the customer has legal title;
 
the customer has physical possession;
 
the customer has significant risk and rewards of ownership; and
 
the customer has accepted the product, or whether customer acceptance is considered a formality based on history of acceptance of similar products (for example, when the customer has previously accepted the same equipment, with the same specifications, and when we can objectively demonstrate that the tool meets all the required acceptance criteria, and when the installation of the system is deemed perfunctory).
 
Not all indicators need to be met for the Company to conclude that control has transferred to the customer. In circumstances in which revenue is recognized prior to the product acceptance, the portion of revenue associated with its performance obligations of product installation and training services are deferred and recognized upon acceptance.
 
The majority of sales under the Manufacturing segment include a standard 12-month warranty. The Company has concluded that the warranty provided for standard products are assurance type warranties and are not separate performance obligations. Warranty provided for customized products are service warranties and are separate performance obligations. Transaction prices are allocated to this performance obligation using cost plus method. The portion of revenue associated with warranty service is deferred and recognized as revenue over the warranty period, as the customer simultaneously receives and consumes the benefits of warranty services provided by the Company.
 
Testing
 
The Company renders testing services to manufacturers and purchasers of semiconductors and other entities who either lack testing capabilities or whose in-house screening facilities are insufficient. The Company primarily derives testing revenue from burn-in services, manpower supply and other associated services. SSP is directly observable from the sales orders. Revenue is allocated to performance obligations satisfied at a point in time depending upon terms of the sales order. Generally, there is no other performance obligation other than what has been stated inside the sales order for each of these sales.
 
Terms of contract that may indicate potential variable consideration include warranty, late delivery penalty and reimbursement to solve non-conformance issues for rejected products. Based on historical and recent data trends, it is concluded that these terms of the contract do not represent potential variable consideration. The transaction price is not contingent on the occurrence of any future event.
 
Distribution
 
The Company distributes complementary products, particularly equipment, industrial products and components by manufacturers mainly from the U.S., Europe, Taiwan and Japan. The Company recognizes revenue from product sales at a point in time when the Company has satisfied its performance obligation by transferring control of the product to the customer. The Company uses judgment to evaluate whether control has transferred by considering several indicators discussed above. The Company recognizes the revenue at a point in time, generally upon shipment or delivery of the products to the customer or distributors, depending upon terms of the sales order. 
 
All inter-segment revenue was from the manufacturing segment to the testing and distribution segments. Total inter-segment revenue was $375 for the three months ended December 31, 2020, as compared to $36 for the same period in the last fiscal year. Corporate assets mainly consisted of cash and prepaid expenses. Corporate expenses mainly consisted of stock option expenses, salaries, insurance, professional expenses and directors' fees. Corporate expenses are allocated to the four segments. The following segment information table includes segment operating income or loss after including the corporate expenses allocated to the segments, which gets eliminated in the consolidation.
 
 
 
The following segment information is unaudited for the six months ended December 31, 2020 and December 31, 2019:
 
Business Segment Information:
 
  Six Months
 Ended
 Dec. 31,
 
Net
 Revenue
 
 
Operating
Income / (Loss)
 
 
Total
 Assets
 
 
Depr.
  and
 Amort.
 
 
Capital
Expenditures
 
Manufacturing2020
 $6,194 
 $63 
 11,739 
 $212 
 $154 

2019
 $6,362 
 $(99)
 10,542 
 $196 
 35 

 
    
    
    
    
    
Testing Services2020
  6,514 
  (673)
  21,900 
  1,222 
  63 

2019
  8,277 
  (93)
  23,314 
  1,344 
  709 

 
    
    
    
    
    
Distribution2020
  2,323 
  244 
  802 
  - 
  - 

2019
  4,113 
  392 
  802 
  2 
  - 

 
    
    
    
    
    
Real Estate2020
  11 
  (61)
  3,846 
  35 
  - 

2019
  33 
  (52)
  3,650 
  34 
  - 

 
    
    
    
    
    
Fabrication 2020
  - 
  - 
  - 
  - 
  - 
Services *2019
  - 
  - 
  27 
  - 
  - 

 
    
    
    
    
    
Corporate &2020
  - 
  63 
  76 
  - 
  - 
Unallocated2019
  - 
  (99)
  120 
  - 
  - 

 
    
    
    
    
    
Total Company2020
 $15,042 
 (364)
 38,363 
 1,469 
 $217 

2019
 $18,785 
 49 
 38,455 
 $1,576 
 $744 
 
The following segment information is unaudited for the three months ended December 31, 2020 and December 31, 2019:
 
Business Segment Information:
 
  Three Months
 Ended
 Dec. 31,
 
Net
 Revenue
 
 
Operating
Income / (Loss)
 
 
Total
 Assets
 
 
Depr.
  and
 Amort.
 
 
Capital
Expenditures
 
Manufacturing2020
 $3,569 
 $81 
 11,739 
 $110 
 $87 

2019
 $3,045 
 $(87)
 10,542 
 $149 
 16 

 
    
    
    
  �� 
    
Testing Services2020
  3,560 
  (336)
  21,900 
  636 
  41 

2019
  3,887 
  (161)
  23,314 
  751 
  189 

 
    
    
    
    
    
Distribution2020
  1,065 
  120 
  802 
  - 
  - 

2019
  2,014 
  188 
  802 
  1 
  - 

 
    
    
    
    
    
Real Estate2020
  7 
  (34)
  3,846 
  20 
  - 

2019
  16 
  (35)
  3,650 
  17 
  - 

 
    
    
    
    
    
Fabrication 2020
  - 
  - 
  - 
  - 
  - 
Services *2019
  - 
  - 
  27 
  - 
  - 

 
    
    
    
    
    
Corporate &2020
  - 
  132 
  76 
  - 
  - 
Unallocated2019
  - 
  (78)
  120 
  - 
  - 

 
    
    
    
    
    
Total Company2020
 $8,201 
 $(37)
 38,363 
 766 
 128 

2019
 $8,962 
 $(173)
 38,455 
 918 
 $205 
 
* Fabrication services is a discontinued operation.
 
 
15. OTHER INCOME
 
Other income consisted of the following:
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
Unaudited
 
 
Unaudited
 
 
Unaudited
 
 
Unaudited
 
Interest income
 $30 
 $52 
 $70 
 $84 
Other rental income
  24 
  30 
  45 
  60 
Exchange loss
  (93)
  (66)
  (137)
  (61)
Bad debt recovery
  - 
  - 
  - 
  11 
Dividend income
  30 
  - 
  32 
  - 
Government grant
  106 
  - 
  260 
  - 
Other miscellaneous income
  46 
  24 
  84 
  56 
      Total
 $143 
 $40 
 $354 
 $150 
 
The Company received financial assistance in the form of government grants from the Singapore and Malaysia governments amid the COVID-19 pandemic. The grants amounted to $101 and $243 for the three and six months ended December 31, 2020, respectively.
 
16.  INCOME TAX
 
The Company is subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgment is required in determining the provision for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws. The statute of limitations, in general, is open for years 2014 to 2020 for tax authorities in those jurisdictions to audit or examine income tax returns. The Company is under annual review by the tax authorities of the respective jurisdiction to which the subsidiaries belong.
 
The Tax Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017, and reduced the U.S. federal corporate tax rate from 35% to 21%, eliminated corporate Alternative Minimum Tax, modified rules for expensing capital investment, and limited the deduction of interest expense for certain companies. The Act is a fundamental change to the taxation of multinational companies, including a shift from a system of worldwide taxation with some deferral elements to a territorial system, current taxation of certain foreign income, a minimum tax on low tax foreign earnings, and new measures to curtail base erosion and promote U.S. production.
 
Due to the enactment of the Tax Act, the Company is subject to a tax on global intangible low-taxed income (“GILTI”).  GILTI is a tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. Companies subject to GILTI have the option to account for the GILTI tax as a period cost if and when incurred, or to recognize deferred taxes for temporary differences including outside basis differences expected to reverse as GILTI. The Company has elected to account for GILTI as a period cost. GILTI expense was $nil for the period ended December 31, 2020.
 
The Company's income tax expense was $nil and $7 for the 3 months and 6 months ended December 31, 2020, respectively as compared to $120 for both 3 months and 6 months ended December 31, 2019. Our effective tax rate (“ETR”) from continuing operations was 0% and 12% for the quarters ended December 31, 2020 and December 31, 2019, respectively. The quarterly ETR is significantly different due to there was a capital gain tax of $94 arising from the sale of an asset held for sale during the three months ended December 31, 2019.
 
The Company accrues penalties and interest related to unrecognized tax benefits when necessary as a component of penalties and interest expenses, respectively. The Company had no unrecognized tax benefits or related accrued penalties or interest expenses at December 31, 2020.
 
In assessing the ability to realize the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on these criteria, management believes it is more likely than not the Company will not realize the benefits of the federal, state, and foreign deductible differences. Accordingly, a full valuation allowance has been established.
 
 
 
17.  CONTRACT BALANCES
 
The timing of revenue recognition, billings and collections may result in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities). The Company’s payment terms and conditions vary by contract type, although terms generally include a requirement of payment of 70% to 90% of total contract consideration within 30 to 60 days of shipment with the remainder payable within 30 days of acceptance. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that its contracts generally do not include a significant financing component.
 
Contract assets were recorded under other receivable while contract liabilities were recorded under accrued expenses in the balance sheet. 
 
The following table is the reconciliation of contract balances.
 
 
 
Dec. 31, 2020 (Unaudited)
 
 
June 30, 2020
 
Trade Accounts Receivable
  7,581 
  5,951 
Accounts Payable
  3,103 
  2,590 
Contract Assets
  360 
  216 
Contract Liabilities
  579 
  476 
 
Remaining Performance Obligation
 
As at December 31, 2020, the Company had $696 of remaining performance obligations, which represents our obligation to deliver products and services. Given the profile of contract terms, approximately 66.7 percent of this amount is expected to be recognized as revenue over the next two years, with the remaining of the amount expected to be recognized between three and five years.
 
Refer to note 14 “Business Segments” of the Notes to Condensed Consolidated Financial Statements for information related to revenue.
 
18.   EARNINGS PER SHARE
 
The Company adopted ASC Topic 260, Earnings Per Share. Basic Earnings Per Share (“EPS”) is computed by dividing net income available to common shareholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during a period.  In computing diluted EPS, the average price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options and warrants.
 
Options to purchase 724,500 shares of Common Stock at exercise prices ranging from $2.53 to $5.98 per share were outstanding as of December 31, 2020. 212,500 stock options were excluded in the computation of diluted EPS for the three months ended December 31, 2020 because they were anti-dilutive.
 
Options to purchase 623,500 shares of Common Stock at exercise prices ranging from $2.69 to $5.98 per share were outstanding as of December 31, 2019. 188,125 stock options were excluded in the computation of diluted EPS for three months ended December 31, 2019 because they were anti-dilutive.
 
 
 
The following table is a reconciliation of the weighted average shares used in the computation of basic and diluted EPS for the period presented herein:  
 
 
 
Three Months Ended
 
 
Six Months Ended  
 
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec.31
 
 
Dec. 31,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
(Unaudited)
 
 
(Unaudited)
 
 
(Unaudited)
 
 
(Unaudited)
 
 
 
 
 
 
 
 
 

 
 

 
Income attributable to Trio-Tech International common shareholders from continuing operations, net of tax
 $246 
 $425 
 $241 
 $699 
Income / (loss) attributable to Trio-Tech International common shareholders from discontinued operations, net of tax
  (11)
  1 
  (14)
  - 
Net income attributable to Trio-Tech International Common Shareholders
 $235 
 $426 
 $227 
 $699 
 
    
    
    
    
Weighted average number of common shares outstanding - basic
  3,710 
  3,673 
  3,710 
  3,673 
 
    
    
    
    
Dilutive effect of stock options
  90 
  52 
  83 
  33 
Number of shares used to compute earnings per share - diluted
  3,800 
  3,725 
  3,793 
  3,706 
 
    
    
    
    
Basic earnings per share from continuing operations attributable to Trio-Tech International
 $0.06 
  0.12 
  0.06 
  0.19 
Basic earnings per share from discontinued operations attributable to Trio-Tech International
  - 
  - 
  - 
  - 
Basic earnings per share from net income attributable to Trio-Tech International
 $0.06 
 $0.12 
 $0.06 
 $0.19 
 
    
    
    
    
Diluted earnings per share from continuing operations attributable to Trio-Tech International
 $0.06 
  0.11 
  0.06 
  0.19 
Diluted earnings per share from discontinued operations attributable to Trio-Tech International
  - 
  - 
  - 
  - 
Diluted earnings per share from net income attributable to Trio-Tech International
 $0.06 
 $0.11 
 $0.06 
 $0.19 
 
19.  STOCK OPTIONS
 
On September 24, 2007, the Company’s Board of Directors unanimously adopted the 2007 Employee Stock Option Plan (the “2007 Employee Plan”) and the 2007 Directors Equity Incentive Plan (the “2007 Directors Plan”), each of which was approved by the shareholders on December 3, 2007. Each of those plans was amended during the term of such plan to increase the number of shares covered thereby. As of the last amendment thereof, the 2007 Employee Plan covered an aggregate of 600,000 shares of the Company’s Common Stock and the 2007 Directors Plan covered an aggregate of 500,000 shares of the Company’s Common Stock. Each of those plans terminated by its respective terms on September 24, 2017. These two plans were administered by the Board, which also established the terms of the awards.
 
On September 14, 2017, the Company’s Board of Directors unanimously adopted the 2017 Employee Stock Option Plan (the “2017 Employee Plan”) and the 2017 Directors Equity Incentive Plan (the “2017 Directors Plan”), each of which was approved by the shareholders on December 4, 2017. Each of these plans is administered by the Board of Directors of the Company.
 
 
 
Assumptions
 
The fair value for the options granted were estimated using the Black-Scholes option pricing model with the following weighted average assumptions, assuming no expected dividends: 
 
 
 
Six Months Ended December 31,
 
 
 
2020
 
 
2019
 
Expected volatility
 
45.38% to 76.85%
 
 
45.38% to 97.48%
 
Risk-free interest rate
 
0.14% to 2.35%
 
 
0.30% to 2.35%
 
Expected life (years)  0.25 - 4.51   2.5 - 3.25 
 
The expected volatilities are based on the historical volatility of the Company’s stock. Due to lower volatility, the observation is made on a daily basis for the three months ended December 31, 2020. The observation period covered is consistent with the expected life of options. The expected life of the options granted to employees has been determined utilizing the “simplified” method as prescribed by ASC Topic 718 Stock Based Compensation, which, among other provisions, allows companies without access to adequate historical data about employee exercise behavior to use a simplified approach for estimating the expected life of a "plain vanilla" option grant. The simplified rule for estimating the expected life of such an option is the average of the time to vesting and the full term of the option. The risk-free rate is consistent with the expected life of the stock options and is based on the United States Treasury yield curve in effect at the time of grant.
 
2017 Employee Stock Option Plan
 
The Company’s 2017 Employee Plan permits the grant of stock options to its employees covering up to an aggregate of 300,000 shares of Common Stock. Under the 2017 Employee Plan, all options must be granted with an exercise price of not less than fair value as of the grant date and the options granted must be exercisable within a maximum of ten years after the date of grant, or such lesser period of time as is set forth in the stock option agreements. The options may be exercisable (a) immediately as of the effective date of the stock option agreement granting the option, or (b) in accordance with a schedule related to the date of the grant of the option, the date of first employment, or such other date as may be set by the Compensation Committee. Generally, options granted under the 2017 Employee Plan are exercisable within five years after the date of grant, and vest over the period as follows: 25% vesting on the grant date and the remaining balance vesting in equal installments on the next three succeeding anniversaries of the grant date. The share-based compensation will be recognized in terms of the grade method on a straight-line basis for each separately vesting portion of the award. Certain option awards provide for accelerated vesting if there is a change in control (as defined in the 2017 Employee Plan).
 
During the first two quarters of fiscal year 2021, there were stock options granted under the 2017 Employee Plan covering a total of 11,000 shares of Common Stock. There were no stock options exercised during the six month period ended December 31, 2020. The Company recognized $15 stock-based compensation expenses during the six months ended December 31, 2020.
 
During the first two quarters of fiscal year 2020, the Company did not grant any options pursuant to the 2017 Employee Plan. There were no stock options exercised during the six-month period ended December 31, 2019. The Company recognized $14 stock-based compensation expenses during the six months ended December 31, 2019.
 
As of December 31, 2020, there were vested stock options granted under the 2017 Employee Plan covering a total of 104,750 shares of Common Stock. The weighted-average exercise price was $4.40 and the weighted average remaining contractual term was 2.96 years.
 
As of December 31, 2019, there were vested stock options granted under the 2017 Employee Plan covering a total of 53,000 shares of Common Stock. The weighted-average exercise price was $4.88 and the weighted average remaining contractual term was 3.63 years.
 
A summary of option activities under the 2017 Employee Plan during the six months period ended December 31, 2020 is presented as follows:
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted Average Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2020
  196,000 
 $3.92 
  3.72 
 $36.00 
Granted
  11,000 
  3.73 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2020
  207,000 
 $3.91 
  3.31 
 $132.49 
Exercisable at December 31, 2020
  104,750 
 $4.40 
  2.96 
 $45.00 
 
 
A summary of the status of the Company’s non-vested employee stock options during the six months ended December 31, 2020 is presented below:
 
 
 
Options
 
 
Weighted Average
Grant-Date
Fair Value
 
 
 
 
 
 
 
 
Non-vested at July 1, 2020
  98,000 
 $3.39 
Granted
  11,000 
  - 
Vested
  (6,750)
  - 
Forfeited
  - 
  - 
Non-vested at December 31, 2020
  102,250 
 $3.40 
 
    
    
 
A summary of option activities under the 2017 Employee Plan during the six months period ended December 31, 2019 is presented as follows:
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted Average Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2019
  136,000 
 $4.53 
  4.28 
 $- 
Granted
  - 
  - 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2019
  136,000 
 $4.53 
  3.77 
 $46.44 
Exercisable at December 31, 2019
  53,000 
 $4.88 
  3.63 
 $12.57 
 
A summary of the status of the Company’s non-vested employee stock options during the six months ended December 31, 2019 is presented below:
 
 
 
Options
 
 
Weighted Average
Grant-Date
Fair Value
 
 
 
 
 
 
 
 
Non-vested at July 1, 2019
  87,000 
 $4.28 
Granted
  - 
  - 
Vested
  (4,000)
  - 
Forfeited
  - 
  - 
Non-vested at December 31, 2019
  83,000 
 $4.30 
 
2007 Employee Stock Option Plan
 
The 2007 Employee Plan terminated by its terms on September 24, 2017 and no further options may be granted thereunder. However, the options outstanding thereunder continue to remain outstanding and in effect in accordance with their terms. The 2007 Employee Plan permitted the issuance of options to employees.
 
As the 2007 Plan has terminated, the Company did not grant any options pursuant to the 2007 Employee Plan during the six months ended December 31, 2020 and December 31, 2019 respectively.
 
There were no options exercised during the six months ended December 31, 2020 and December 31, 2019. The Company did not recognize any stock-based compensation expenses during the six months ended December 31, 2020 and December 31, 2019.
 
As of December 31, 2020, there were vested stock options granted under the 2007 Employee Plan covering a total of 77,500 shares of Common Stock. The weighted-average exercise price was $3.69 and the weighted average remaining contractual term was 0.71 years.
 
 
 
As of December 31, 2019, there were vested stock options granted under the 2007 Employee Plan covering a total of 68,125 shares of Common Stock. The weighted-average exercise price was $3.62 and the weighted average remaining contractual term was 1.64 years.
 
A summary of option activities under the 2007 Employee Plan during the six months ended December 31, 2020 is presented as follows:
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted Average Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2020
  77,500 
 $3.69 
  1.22 
 $- 
Granted
  - 
  - 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2020
  77,500 
 $3.69 
  0.71 
 $28.00 
Exercisable at December 31, 2020
  77,500 
 $3.69 
  0.71 
 $28.00 
 
There were no non-vested employee stock options during the six months ended December 31, 2020.
 
A summary of option activities under the 2007 Employee Plan during the six months ended December 31, 2019 is presented as follows:
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted Average Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2019
  77,500 
 $3.69 
  2.22 
 $- 
Granted
  - 
  - 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2019
  77,500 
  3.69 
  1.71 
 $29.20 
Exercisable at December 31, 2019
  68,125 
 $3.62 
  1.64 
 $29.20 
 
A summary of the status of the Company’s non-vested employee stock options under the 2007 Employee Plan during the six months ended December 31, 2019 is presented below:
 
 
 
Options
 
 
Weighted Average
Grant-Date
Fair Value
 
 
 
 
 
 
 
 
Non-vested at July 1, 2019
  9,375 
 $4.14 
Granted
  - 
  - 
Vested
  - 
  - 
Forfeited
  - 
  - 
Non-vested at December 31, 2019
  9,375 
 $4.14 
 
 
 
2017 Directors Equity Incentive Plan
 
The 2017 Directors Plan initially covered an aggregate of 300,000 shares of the Company’s common stock. The Company’s board of directors approved an amendment to the 2017 Directors Plan in September 2020 to increase the shares covered thereby from 300,000 shares to an aggregate of 600,000 shares, which amendment was approved by the Company’s shareholders at the annual meeting held in December 2020. The 2017 Directors Plan permits the grant of options to its directors in the form of non-qualified options and restricted stock. The exercise price of the non-qualified options is required to be 100% of the fair value of the underlying shares on the grant date. The options have five-year contractual terms and are exercisable immediately as of the grant date.
 
During the first two quarters of fiscal year 2021, the Company did not grant any options pursuant to the 2017 Directors Plan. There were no stock options exercised during the six months ended December 31, 2020. The Company did not recognize any stock-based compensation expenses during the six months ended December 31, 2020.
 
During the first two quarters of fiscal year 2020, the Company did not grant any options pursuant to the 2017 Directors Plan. There were no stock options exercised during the six months ended December 31, 2019. The Company did not recognize any stock-based compensation expenses during the six months ended December 31, 2019.
 
As all the stock options granted under the 2017 Directors Plan vest immediately on the date of grant, there were no unvested stock options granted under the 2017 Directors Plan as of December 31, 2020 or December 31, 2019.
 
As of December 31, 2020, there were vested stock options granted under the 2017 Directors Plan covering a total of 240,000 shares of Common Stock. The weighted-average exercise price was $3.93 and the weighted average remaining contractual term was 3.24 years.
 
As of December 31, 2019, there were vested stock options granted under the 2017 Directors Plan covering a total of 160,000 shares of Common Stock. The weighted-average exercise price was $4.63 and the weighted average remaining contractual term was 3.75 years.
 
A summary of option activities under the 2017 Directors Plan during the six months ended December 31, 2020 is presented as follows: 
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted Average Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2020
  240,000 
 $3.93 
  3.75 
 $48.00 
Granted
  - 
  - 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2020
  240,000 
 $3.93 
  3.24 
 $168.80 
Exercisable at December 31, 2020
  240,000 
 $3.93 
  3.24 
 $168.80 
 
A summary of option activities under the 2017 Directors Plan during the six months ended December 31, 2019 is presented as follows: 
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted Average Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2019
  160,000 
 $4.63 
  4.25 
 $- 
Granted
  - 
  - 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2019
  160,000 
 $4.63 
  3.75 
 $56.80 
Exercisable at December 31, 2019
  160,000 
 $4.63 
  3.75 
 $56.80 
 
 
 
2007 Directors Equity Incentive Plan
 
The 2007 Directors Plan terminated by its terms on September 24, 2017 and no further options may be granted thereunder. However, the options outstanding thereunder continue to remain outstanding and in effect in accordance with their terms. The 2007 Directors Plan permitted the issuance of options to directors.
 
As the 2007 Plan has terminated, the Company did not grant any options pursuant to the 2007 Directors Plan during the six months ended December 31, 2020 and December 31, 2019.
 
50,000 shares of stock options were exercised during the six months ended December 31, 2020. The Company did not recognize any stock-based compensation expenses during the six months ended December 31, 2020.
 
There were no stock options exercised during the six months ended December 31, 2019. The Company did not recognize any stock-based compensation expenses during the six months ended December 31, 2019.
 
As of December 31, 2020, there were vested stock options granted under the 2007 Directors Plan covering a total of 200,000 shares of Common Stock. The weighted-average exercise price was $3.48 and the weighted average remaining contractual term was 0.47 years.
 
As of December 31, 2019, there were vested stock options granted under the 2007 Directors Plan covering a total of 250,000 shares of Common Stock. The weighted-average exercise price was $3.32 and the weighted average remaining contractual term was 1.33 years.
  
A summary of option activities under the 2007 Directors Plan during the six months ended December 31, 2020 is presented as follows: 
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted
Average
Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2020
  250,000 
 $3.32 
  0.83 
 $22.00 
Granted
  - 
  - 
  - 
  - 
Exercised
  (50,000)
  2.69 
  - 
  - 
Forfeited or expired
  - 
  - 
  - 
  - 
Outstanding at December 31, 2020
  200,000 
 $3.48 
  0.47 
 $105.00 
Exercisable at December 31, 2020
  200,000 
 $3.48 
  0.47 
 $105.00 
 
A summary of option activities under the 2007 Directors Plan during the six months ended December 31, 2019 is presented as follows: 
 
 
 
Options
 
 
Weighted Average
Exercise
Price
 
 
Weighted
Average
Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at July 1, 2019
  300,000 
 $3.40 
  1.58 
 $9.00 
Granted
  - 
  - 
  - 
  - 
Exercised
  - 
  - 
  - 
  - 
Forfeited or expired
  (50,000)
  (3.81)
  - 
  - 
Outstanding at December 31, 2019
  250,000 
 $3.32 
  1.33 
 $174.50 
Exercisable at December 31, 2019
  250,000 
 $3.32 
  1.33 
 $174.50 
 
 
 
20.  LEASES
 
Company as Lessor
 
Operating leases where we are lessor arise from the leasing of the Company’s commercial and residential real estate investment property. Initial lease terms generally range from 12 to 60 months. Depreciation expense for assets subject to operating leases is taken into account primarily on the straight-line method over a period of twenty years in amounts necessary to reduce the carrying amount of the asset to its estimated residual value. Depreciation expenses relating to the property held as investments in operating leases was $18 for both the 3 months ended December 31, 2020 and December 31, 2019.
 
Future minimum rental income in China and Thailand to be received from fiscal year 2021 to fiscal year 2022 on non-cancelable operating leases is contractually due as follows as of December 31, 2020:
 
2021
 $68 
2022
  110  
 
 $178 
 
Future minimum rental income in China and Thailand to be received from fiscal year 2021 to fiscal year 2022 on non-cancelable operating leases is contractually due as follows as of June 30, 2020:
 
2021
 $120  
2022
  114  
 
 $234 
 
Company as Lessee
 
The Company is the lessee under operating leases for corporate offices and research and development facilities with remaining lease terms of 1 year to 3 years and finance leases for plant and equipment.
 
Supplemental balance sheet information related to leases was as follows (in thousands):
 
 
Dec. 31,
2020
(Unaudited)
 
 
June 30,
2020
 
Finance Leases (Plant and Equipment)
 
 
 
 
 
 
Plant and equipment, at cost
 $1,880 
 $1,372 
Accumulated depreciation
  (864)
  (526)
      Plant and Equipment, Net
 $1,016 
 $846 
 
    
    
Current portion of finance leases
  227 
  231 
Net of current portion of finance leases
  353 
  435 
      Total Finance Lease Liabilities
 $580 
 $666 
 
    
    
Operating Leases (Corporate Offices, Research and Development Facilities)
    
    
Operating lease right-of-use assets
  1,514 
  944 
Current portion of operating leases
  562 
  477 
Net of current portion of operating leases
  952 
  467 
      Total Operating Lease Liabilities
 $1,514 
 $944 
 
    
    
 
 
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
(Unaudited)
 
 
(Unaudited)
 
 
(Unaudited)
 
 
(Unaudited)
 
Lease Cost
 
 
 
 
 
 
 
 
 
 
 
Finance lease cost:
 
 
 
 
 
 
 
 
 
 
 
 
Interest on finance lease
 $8 
 $3 
 $20 
 $24 
Amortization of right-of -use assets
  63 
  69 
  125 
  136 
Total finance lease cost
 $71 
 $72 
 $145 
 $160 
 
    
    
    
    
Operating Lease Costs
 $189 
 $184 
 $375 
 $359 
 
Other information related to leases was as follows (in thousands except lease term and discount rate):
 
 
 
Six months ended
 
 
Six months ended
 
 
 
December 31,
 
 
December 31,
 
 
 
2020
 
 
2019
 
 
 
(Unaudited)
 
 
(Unaudited)
 
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
 
 
 
 
 
 
      Operating cash flows from finance leases
 $19 
 $24 
      Operating cash flows from operating leases
 $375 
 $359 
      Finance cash flows from finance leases
 $- 
 $127 
Right-of-Use Assets Obtained in Exchange for New Operating Lease Liabilities
  847 
  - 
Weighted-Average Remaining Lease Term:
    
    
      Finance leases
  3.31 
  3.67 
      Operating leases
  2.97 
  0.97 
Weighted-Average Discount Rate:
    
    
      Finance leases
  3.36%
  3.43%
      Operating leases
  4.72%
  3.25%
 
As of December 31, 2020, future minimum lease payments under finance leases and non-cancelable operating leases were as follows:
 
 
 
Operating
Lease
Liabilities
 
 
Finance
Lease
Liabilities 
 
Fiscal Year
 
 
 
 
 
 
Remainder of 2021
 $625 
 $137 
2022
  519 
  220 
2023
  235 
  141 
2024
  151 
  114 
2025
  114 
  22 
Total future minimum lease payments
  1,644 
  634 
Less: amount representing interest
  (130)
  (54)
Present value of net minimum lease payments
 $1,514 
 $580 
 
    
    
Presentation on statement of financial position
    
    
Current
 $562 
 $227 
Non-current
 $952 
 $353 
 
 
 
As of June 30, 2020, future minimum lease payments under finance leases and non-cancelable operating leases were as follows:
 
 
 
Operating
Lease
Liabilities
 
 
Finance
Lease
Liabilities 
 
Fiscal Year
 
 
 
 
 
 
2021
 $509 
 $265 
2022
  317 
  211 
2023
  168 
  133 
2024
  - 
  107 
2025
  - 
  20 
Total future minimum lease payments
  994 
  736 
Less: amount representing interest
  (50)
  (70)
Present value of net minimum lease payments
 $944 
 $666 
Presentation on statement of financial position
    
    
Current
 $477 
  231 
Non-current
 $467 
  435 
 
21.  FAIR VALUE OF FINANCIAL INSTRUMENTS APPROXIMATE CARRYING VALUE
 
In accordance with ASC Topics 825 and 820, the following presents assets and liabilities measured and carried at fair value and classified by level of fair value measurement hierarchy:
 
There were no transfers between Levels 1 and 2 during the three months ended December 31, 2020 and 2019.
 
Term deposits (Level 2) – The carrying amount approximates fair value because of the short maturity of these instruments.
 
Restricted term deposits (Level 2) – The carrying amount approximates fair value because of the short maturity of these instruments.
 
PPP loan (Level 2) – The carrying amount approximates its fair value based on similar short-term debt issues available to the Company.
 
Lines of credit (Level 3) – The carrying value of the lines of credit approximates fair value due to the short-term nature of the obligations.
 
Bank loans payable (Level 3) – The carrying value of the Company’s bank loans payables approximates its fair value as the interest rates associated with long-term debt is adjustable in accordance with market situations when the Company borrowed funds with similar terms and remaining maturities.
 
 
22. PAYCHECK PROTECTION PROGRAM LOAN
 
The Coronavirus Aid, Relief, and Economic Security (CARES) Act created the Paycheck Protection Program (PPP) to provide certain small businesses with liquidity to support their operations during the COVID-19 pandemic. The PPP is a loan program designed to provide a direct incentive for small businesses to keep their employees on payroll.
 
The loans have a 1% fixed interest rate and are due in two years with payment deferred for the first six months. However, they are eligible for forgiveness (in full or in part, including any accrued interest) under certain conditions and are subject to audit by the U.S. government. The loans will be forgiven if the loan proceeds were used for eligible purposes, including payroll, benefits, rent and utilities, and the Company maintained its payroll levels for eight weeks.
 
In May 2020, the Company received loan proceeds in the amount of approximately $121 under the PPP. The Company accounted for the PPP loan as a financial liability in accordance with Accounting Standards Codification (ASC) 470 Debt after considering the following aspects: (1) the legal form of a PPP loan is debt regardless of whether the Company expects the loan to be forgiven (2) given the degree of uncertainty and complexity surrounding the PPP loan forgiveness process, this may impact a Company’s initial assessment.
 
Under ASC 470, the Company recognizes a liability for the full amount of PPP proceeds received and accrues interest over the term of the loan. No additional interest was imputed at a market rate because the guidance on imputing interest in ASC 835-30 excludes transactions where interest rates are prescribed by a government agency. If any amount is ultimately forgiven (i.e., the Company is legally released from being the loan’s primary obligor in accordance with ASC 405-20), income from the extinguishment of the liability would be recognized in the income statement as a gain on loan extinguishment. The Company intended to use the proceeds for purposes consistent with the PPP. Hence, the Company expects that its use of the loan proceeds will meet the conditions for forgiveness of the loan. In considering the term of the loan and payment deferred portion, the Company determined that the loan would be presented as a current portion of $121 in the balance sheet.
 
 
 
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
 
Overview
 
The following should be read in conjunction with the condensed consolidated financial statements and notes in Item I above and with the audited consolidated financial statements and notes, the information under the headings “Risk Factors” and “Management’s discussion and analysis of financial condition and results of operations” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2020.
 
Trio-Tech International (“TTI”) was incorporated in 1958 under the laws of the State of California. As used herein, the term “Trio-Tech” or “Company” or “we” or “us” or “Registrant” includes Trio-Tech International and its subsidiaries unless the context otherwise indicates. Our mailing address and executive offices are located at Block 1008 Toa Payoh North, Unit 03-09 Singapore 318996, and our telephone number is (65) 6265 3300.
 
The Company is a provider of reliability test equipment and services to the semiconductor industry. Our customers rely on us to verify that their semiconductor components meet or exceed the rigorous reliability standards demanded for aerospace, communications and other electronics products.
 
TTI generated approximately 99.9% of its revenue from its three core business segments in the test and measurement industry, i.e. manufacturing of test equipment, testing services and distribution of test equipment during the three months ended December 31, 2020. The Real Estate segment contributed only 0.1% to the total revenue during the three months ended December 31, 2020.
 
Manufacturing
 
TTI develops and manufactures an extensive range of test equipment used in the "front end" and the "back end" manufacturing processes of semiconductors. Our equipment includes leak detectors, autoclaves, centrifuges, burn-in systems and boards, HAST testers, temperature-controlled chucks, wet benches and more.
 
Testing
 
TTI provides comprehensive electrical, environmental, and burn-in testing services to semiconductor manufacturers in our testing laboratories in Asia and the U.S. Our customers include both manufacturers and end-users of semiconductor and electronic components who look to us when they do not want to establish their own facilities. The independent tests are performed to industry and customer specific standards.
 
Distribution
 
In addition to marketing our proprietary products, we distribute complementary products made by manufacturers mainly from the U.S., Europe, Taiwan and Japan. The products include environmental chambers, handlers, interface systems, vibration systems, shaker systems, solderability testers and other semiconductor equipment. Besides equipment, we also distribute a wide range of components such as connectors, sockets, LCD display panels and touch-screen panels. Furthermore, our range of products are mainly targeted for industrial products rather than consumer products whereby the life cycle of the industrial products can last from 3 years to 7 years.
 
Real Estate
 
Beginning in 2007, TTI has invested in real estate property in Chongqing, China, which has generated investment income from rental revenue, and investment returns from deemed loan receivables, which are classified as other income. The rental income is generated from the rental properties in MaoYe and FuLi in Chongqing, China. In the second quarter of fiscal 2015, the investment in JiaSheng, which was deemed as loans receivable, was transferred to down payment for purchase of investment property in China.
 
Impact of COVID-19 on our Business
 
In December 2019, a novel strain of coronavirus (“COVID-19”), was reported to have surfaced in China, resulting in shutdowns of manufacturing and commerce in the months that followed. Since then, the COVID-19 pandemic has spread to multiple countries worldwide and has resulted in authorities implementing numerous measures to try to contain the disease and slow its spread, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. These measures have created significant uncertainty and economic disruption, both short-term and potentially long-term.
 
 
 
The health and safety of our employees and our customers are a top priority for us. In an effort to protect our employees, we took and continue to take proactive and aggressive actions, starting with the earliest signs of the outbreak, to adopt social distancing policies at our locations, including working from home and suspending employee travel. Our operations have been classified as part of the global supply chain and essential businesses in many jurisdictions, and employees who are working onsite are required to adhere to strict safety measures, including the use of masks and sanitizer, wellness screenings prior to accessing work sites, staggered break times to prevent congregation, prohibitions on physical contact with co-workers or customers, restrictions on access through only a single point of entry and exit, and utilizing video conferencing. We have also incorporated other rules such as restricting visitors to any of our facilities that remain open and proactively providing employees with hand sanitizer.
 
The most significant near-term impacts of the ongoing COVID-19 pandemic on our financial performance are declines in customers’ volume of testing services, customers’ order in our distribution segment, and a delay in deliveries for our manufacturing segment. We see a sign of recovery as there was an improvement in the manufacturing segment’s financial performance in the second quarter of fiscal 2021, as discussed below.
 
The Company received an aggregate of $243 in government assistance in the Singapore, and Malaysia operations to mitigate the adverse impact on the business from the pandemic. The Company believes that, as with other business entities in Singapore, it will receive additional government assistance for a period to ease the financial impact caused by the pandemic. The Company also received a PPP loan of $121 in the US operations to support the business amid the pandemic.
 
As of December 31, 2020, the Company had cash and cash equivalents and short-term deposits totaling $11,410 and an unused line of credit of $6,187. We finance operations primarily through our existing cash balances, cash collected from operations, bank borrowings and capital lease financing. We believe these sources are sufficient to fund our operations for the foreseeable future.
 
While we have implemented safeguards and procedures to counter the impact of the COVID-19 pandemic, the full extent to which the pandemic has and will directly or indirectly impact us, including our business, financial condition, and result of operations, will depend on future developments that are highly uncertain and cannot be accurately predicted. This may include further mitigation efforts taken to contain the virus or treat its impact and the economic impact on local, regional, national and international markets. We will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by the governments or that we determine are in the best interests of our employees, customers, suppliers and stockholders.
 
Second Quarter Fiscal Year 2021 Highlights
 
Total revenue decreased by $761, or 8.5%, to $8,201 in the second quarter of fiscal year 2021, compared to $8,962 for the same period in fiscal year 2020.
Manufacturing segment revenue increased by $524, or 17.2%, to $3,569 for the second quarter of fiscal year 2021, compared to $3,045 for the same period in fiscal year 2020.
Testing segment revenue decreased by $327, or 8.4%, to $3,560 for the second quarter of fiscal year 2021, compared to $3,887 for the same period in fiscal year 2020.
Distribution segment revenue decreased by $949, or 47.1%, to $1,065 for the second quarter of fiscal year 2021, compared to $2,014 for the same period in fiscal year 2020.
Real estate segment rental revenue decreased by $9 or 56.3% to $7 for the second quarter of fiscal year 2021, compared to $16 for the same period in fiscal year 2020.
The overall gross profit margin increased by 1.5% to 22.8% for the second quarter of fiscal year 2021, from 21.3% for the same period in fiscal year 2020.
General and administrative expenses decreased by $115, or 6.5%, to $1,662 for the second quarter of fiscal year 2021, from $1,777 for the same period in fiscal year 2020.
Selling expenses decreased by $54, or 30.7%, to $122 for the second quarter of fiscal year 2021, from $176 for the same period in fiscal year 2020.
Other income increased by $103 to $143 in the second quarter of fiscal year 2020, compared to $40 in the same period in fiscal year 2020.
Loss from operations was $37 for the second quarter of fiscal year 2021, a decrease of $136 as compared to $173 for the same period in fiscal year 2020.
Income tax expenses was $nil in the second quarter of fiscal year 2021, a decrease of $120 as compared to an income tax expense of $120 in the same period in fiscal year 2020.
During the second quarter of fiscal year 2021, profit from continuing operations before non-controlling interest, net of tax was $72, as compared to income from continuing operations before non-controlling interest of $864 for the same period in fiscal year 2020.
Net loss attributable to non-controlling interest for the second quarter of fiscal year 2021 was $184, a deterioration of $623 as compared to net profit attributable to non-controlling interest of $439 in the same period in fiscal year 2020.
Basic earnings per share for the second quarter of fiscal year 2021 were $0.06, as compared to earnings per share of $0.12 for the same period in fiscal year 2020.
Dilutive earnings per share for the second quarter of fiscal year 2021 were $0.06, as compared to earnings per share of $0.11 for the same period in fiscal year 2020.
Total assets increased by $2,703 to $38,363 as of December 31, 2020, compared to $35,660 as of June 30, 2020.
Total liabilities increased by $1,301 to $11,815 as of December 31, 2020, compared to $10,514 as of June 30, 2020.
 
 
 
Results of Operations and Business Outlook
 
The following table sets forth our revenue components for both three months and six months ended December 31, 2020 and 2019, respectively.
 
Revenue Components
 
Three Months Ended
 
 
Six Months Ended
 
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
Dec. 31,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manufacturing
  43.5%
  34.0%
  41.2%
  33.9%
Testing Services
  43.4 
  43.4 
  43.3 
  44.1 
Distribution
  13.0 
  22.4 
  15.4 
  21.8 
Real Estate
  0.1 
  0.2 
  0.1 
  0.2 
Total
  100.0%
  100.0%
  100.0%
  100.0%
 
Revenue for the three and six months ended December 31, 2020 was $8,201 and $15,042, respectively, a decrease of $761 and $3,743, respectively, when compared to the revenue for the same period of the prior fiscal year. As a percentage, revenue decreased by 8.5% and 19.9% for the three and six months ended December 31, 2020, respectively, when compared to revenue for the same period of the prior year.
 
For the three months ended December 31, 2020, the $761 decrease in overall revenue was primarily due to
 
a decrease in the testing segment in the Malaysia operation; and
a decrease in the distribution segment in the Singapore operation.
 
These decreases were partially offset by:
 
an increase in the manufacturing segment in the U.S. and Singapore operations; and
an increase in the testing segments in the China and Thailand operations.
 
For the six months ended December 31, 2020, the $3,743 decrease in overall revenue was primarily due to:
 
a decrease in the manufacturing segment in the Singapore operations;
a decrease in the testing segment in the Singapore, Malaysia and China operations; and
a decrease in the distribution segment in the Singapore operation.
 
These decreases were partially offset by:
 
an increase in the manufacturing segment in the U.S. operation; and
an increase in the testing segment in the Thailand operation.
 
Total revenue into and within China, the Southeast Asia regions and other countries (except revenue into and within the United States) decreased by $1,004 (or 11.4%), to $7,827 and by $3,783 (or 21.0%) to $14,235 for the three and six months ended December 31, 2020, respectively, as compared with $8,831 and $18,018, respectively, for the same period of last fiscal year. 
 
Total revenue into and within the U.S. was $374 and $807 for the three and six months ended December 31, 2020, respectively, an increase of $243 and $40 from $131 and $767 for the same periods of the prior year, respectively.
 
Revenue within our four current segments for the three and six months ended December 31, 2020 is discussed below.
 
Manufacturing Segment
 
Revenue in the manufacturing segment was 43.5% and 41.2% as a percentage of total revenue for the three and six months ended December 31, 2020, respectively, an increase of 9.5% and 7.3% of total revenue, respectively, when compared to the same periods of the last fiscal year. The absolute amount of revenue increased by $524 to $3,569 from $3,045 and decreased by $168 to $6,194 from $6,362 for the three and six months ended December 31, 2020, respectively, compared to the same periods of the last fiscal year. 
 
Revenue in the manufacturing segment for the three months ended December 31, 2020 increased primarily due to an increase in orders by customers in the Singapore and U.S. operations in the second quarter. Despite substantial headwinds caused by the pandemic, the demand for our equipment was strong in this quarter.
 
 
 
Revenue in the manufacturing segment from one customer accounted for 42.4% and 39.7% of our total revenue in the manufacturing segment for the three months ended December 31, 2020 and 2019, respectively, and 29.7% and 39.5% of our total revenue in the manufacturing segment for the six months ended December 31, 2020, and 2019, respectively.
 
The future revenue in our manufacturing segment will be affected by this one customer's purchase and capital expenditure plans if the customer base cannot be increased.
 
Testing Services Segment
 
The testing segment's revenue was 43.4% of total revenue for the three months ended December 31, 2020 and 2019, respectively. Revenue in the testing segment was 43.3% as a percentage of total revenue for the six months ended December 31, 2020, a decrease of 0.8% compared to the same period of the last fiscal year. The absolute amount of revenue decreased by $327 to $3,560 from $3,887 and decreased by $1,763 to $6,514 from $8,277 for the three and six months ended December 31, 2020, respectively, as compared to the same periods of the last fiscal year. 
 
The revenue in the testing segment from the one customer noted above accounted for 61.1% and 61.6% of our revenue in the testing segment for the three months ended December 31, 2020 and 2019, respectively, and 58.8% and 64.1% of our total revenue in the testing segment for the six months ended December 31, 2020 and 2019, respectively. The future revenue in the testing segment will be affected by the demands of this customer if the customer base cannot be increased. Demand for testing services varies from country to country, depending on any changes taking place in the market and our customers’ forecasts. As it is challenging to forecast fluctuations in the market accurately, management believes it is necessary to maintain testing facilities in close proximity to the customers in order to make it convenient for them to send us their newly manufactured parts for testing and to enable us to maintain a share of the market.
 
Distribution Segment
 
Revenue in the distribution segment was 13.0% and 15.4% as a percentage of total revenue for the three and six months ended December 31, 2020, respectively, a decrease of 9.4% and 6.4%, respectively, compared to the same periods of the last fiscal year. The absolute amount of revenue decreased by $949 to $1,065 from $2,014 and decreased by $1,790 to $2,323 from $4,113 for the three and six months ended December 31, 2020, respectively, compared to the same periods of the last fiscal year. 
 
Demand for the distribution segment varies depending on the demand for our customers’ products, the changes taking place in the market, and our customers’ forecasts.  Hence it is difficult to forecast fluctuations in the market accurately.
 
Real Estate Segment
 
The real estate segment accounted for 0.1% of total revenue for both the three and six months ended December 31, 2020, respectively. The absolute amount of revenue in the real estate segment decreased by $9 to $7 from $16 and decreased by $22 to $11 from $33 for the three and six months ended December 31, 2020, respectively, compared to the same periods of the last fiscal year. The decrease in rental income was mainly due to a decrease in demand amid the uncertainties brought by the pandemic.
 
Uncertainties and Remedies
 
Several influencing factors create uncertainties when forecasting performance, such as the constantly changing nature of technology, specific customer requirements, a decline in demand for certain types of burn-in devices or equipment, decline in demand for testing services and fabrication services, and other similar factors. One influencing factor is the highly competitive nature of the semiconductor industry. Additionally, some customers are unable to provide a forecast of the products required in the upcoming weeks; hence it is difficult to plan for the resources needed to meet these customers’ requirements due to short lead time and last-minute order confirmation. This will generally result in a lower margin for these products as it is more expensive to purchase materials in a short time frame. However, the Company has taken particular actions and formulated specific plans to deal with and help mitigate these unpredictable factors. For example, in order to meet manufacturing customers’ demands upon short notice, the Company maintains higher inventories, but continues to work closely with its customers to avoid stockpiling. We believe that we have improved customer service from staff through our efforts to keep our staff up to date on the newest technology and stress the importance of understanding and meeting our customers' stringent requirements. Finally, the Company is exploring new markets and products, looking for new customers, and upgrading and improving burn-in technology while at the same time searching for improved testing methods for higher technology chips.
 
We are in the process of implementing an Enterprise Resource Planning System as part of a multi-year plan to integrate and upgrade our systems and processes. The implementation of this ERP system was scheduled to occur in phases over a few years. The operational and financial systems in our Singapore and Malaysia operations were transitioned to the new system in fiscal 2018 and fiscal 2019, respectively.
 
 
 
The operational and financial systems in our Tianjin and Suzhou operations have been fully transitioned to the new system during the second quarter of fiscal 2021. This implementation effort will continue till the Company's consolidation process is substantially automated using the new system.
 
As a phased implementation of this system occurs, we are experiencing certain changes to our processes and procedures which, in turn, result in changes to our internal control over financial reporting. While we expect the new ERP system to strengthen our internal financial controls by automating certain manual processes and standardizing business processes and reporting across our organization, management will continue to evaluate and monitor our internal controls as processes and procedures in each of the affected areas evolve.
 
The Company’s primary exposure to movements in foreign currency exchange rates relates to non-U.S. dollar-denominated sales and operating expenses in its subsidiaries. Strengthening of the U.S. dollar relative to foreign currencies adversely affects the U.S. dollar value of the Company’s foreign currency-denominated sales and earnings. Generally, it leads the Company to raise international pricing, potentially reducing demand for the Company’s products. Margins on sales of the Company’s products in foreign countries and on sales of products that include components obtained from foreign suppliers could be materially adversely affected by foreign currency exchange rate fluctuations. In some circumstances, for competitive or other reasons, the Company may decide not to raise local prices to fully offset the dollar’s strengthening, or at all, which would adversely affect the U.S. dollar value of the Company’s foreign currency-denominated sales and earnings. Conversely, a strengthening of foreign currencies relative to the U.S. dollar, while generally beneficial to the Company’s foreign currency denominated sales and earnings, could cause the Company to reduce international pricing, thereby limiting the benefit. Additionally, strengthening of foreign currencies may also increase the Company’s cost of product components denominated in those currencies, thus adversely affecting gross margins.
 
In December 2019, COVID-19 was reported to have surfaced in China, resulting in shutdowns of manufacturing and commerce in the months that followed. Since then, the COVID-19 pandemic has spread to multiple countries worldwide and has resulted in authorities implementing numerous measures to try to contain the disease and slow its spread, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. These measures have created significant uncertainty and economic disruption, both short-term and potentially long-term.
 
The spread of COVID-19 has caused us to modify our business practices (including employee travel, employee work locations, and cancellation of physical participation in meetings, events, and conferences), and we may take further actions as may be required by government authorities or that we determine are in the best interest of our employees, customers, partners, and suppliers. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus and our ability to perform critical functions could be harmed.
 
The degree to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including but not limited to, the duration and spread of the pandemic, its severity, the action to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 pandemic has subsided, we may experience material adverse impacts on our business as a result of the global economic impact and any recession that has occurred or may occur in the future. There are no comparable recent events that provide guidance as to the effect the spread of COVID-19 as a global pandemic may have, and, as a result, the ultimate impact of the pandemic on our operations and financial results is highly uncertain and subject to change.
 
Comparison of the Three Months Ended December 31, 2020 and December 31, 2019
 
The following table sets forth certain consolidated statements of income data as a percentage of revenue for the three months ended December 31, 2020 and 2019 respectively:
 
 
 
Three Months Ended
December 31,
 
 
 
2020
 
 
2019
 
Revenue
  100.0%
  100.0%
Cost of sales
  77.2 
  78.7 
Gross Margin
  22.8%
  21.3%
Operating expenses
    
    
General and administrative
  20.3%
  19.8%
Selling
  1.5 
  2.0 
Research and development
  1.5 
  1.4 
Total operating expenses
  23.3%
  23.2%
Loss from Operations
  (0.5)%
  (1.9)%
 
 
 
Overall Gross Margin
 
Overall gross margin as a percentage of revenue increased by 1.5% to 22.8% for the three months ended December 31, 2020, from 21.3% for the same period of the last fiscal year.
 
Gross profit margin as a percentage of revenue in the manufacturing segment increased by 0.7% to 22.4% for the three months ended December 31, 2020, as compared to 21.7% for the same period in the last fiscal year. In absolute dollar amounts, gross profits in the manufacturing segment increased by $137 to $799 for the three months ended December 31, 2020, from $662 for the same period in the last fiscal year.
 
Gross profit margin as a percentage of revenue in the testing segment remained comparable at 24.8% for the three months ended December 31, 2020, compared to 24.9% in the same period of the last fiscal year. Significant portions of our cost of goods sold are fixed in the testing segment.  Thus, as the demand for services and factory utilization decreases, the fixed costs are spread over the decreased output, which decreases the gross profit margin. Despite a decrease in the testing revenue, we improved the testing segment’s gross margin as a result of cost control measures. In absolute dollar amounts, gross profit in the testing segment decreased by $87 to $882 for the three months ended December 31, 2020 from $969 for the same period of the last fiscal year.
 
Gross profit margin of the distribution segment is not only affected by the market price of the products we distribute, but also the mix of products we distribute, which frequently changes as a result of fluctuations in market demand. Gross profit margin as a percentage of revenue in the distribution segment increased by 5.5% to 19.2% for the three months ended December 31, 2020, from 13.7% in the same period of the last fiscal year. The increase in gross margin was due to the increase in sales of high-profit margin products in our Singapore operation compared to the same period of last fiscal year. In absolute dollar amounts, gross profit in the distribution segment for the three months ended December 31, 2020 was $204 compared to $276 in the same period of the last fiscal year. 
 
In absolute dollar amounts, for the three months ended December 31, 2020, gross loss in the real estate segment was $15, as compared to $2 for the same period of last fiscal year. The increase in gross loss was mainly due to a decrease in rental income amid the pandemic.
 
Operating Expenses
 
Operating expenses for the three months ended December 31, 2020 and 2019 were as follows:
 
 
 
Three Months Ended
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
General and administrative
 $1,662 
 $1,777 
Selling
  122 
  176 
Research and development
  123 
  125 
Total
 $1,907 
 $2,078 
 
General and administrative expenses decreased by $115, or 6.5%, from $1,777 to $1,662 for the three months ended December 31, 2020 compared to the same period of last fiscal year. The decrease in general and administrative expenses was mainly attributable to the lower payroll and staff-related expenses in the Singapore operations resulting from the pandemic. In addition, the absence of doubtful debts provision for the three months ended December 31, 2020 also contributed to a decrease in general and administrative expenses.
 
Selling expenses decreased by $54, or 30.7%, from $176 to $122 for the three months ended December 31, 2020 compared to the same period of the last fiscal year. The decrease in selling expenses was primarily attributable to the worldwide travel restrictions imposed to contain the pandemic's spread, which resulted in lower traveling expenses.
  
Loss from Operations
 
Loss from operations was $37 for the three months ended December 31, 2020, a decrease of $136, compared to $173 for the same period of last fiscal year. The result was mainly due to the increase in gross profit margin and the decrease in operating expenses, as previously discussed.
 
 
 
Interest Expense
 
Interest expense for the three months ended December 31, 2020 and 2019 were as follows:
 
 
 
Three Months Ended
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
Interest expenses
 $34 
 $55 
 
Interest expense was $34 for the three months ended December 31, 2020, a decrease of $21, or 38.2%, compared to $55 for the three months ended December 31, 2019. The decrease was primarily due to a decrease in the utilization of short-term loans in the Singapore operations. As of December 31, 2020, the Company had an unused line of credit of $6,187 as compared to $6,325 at December 31, 2019.
 
Other Income
 
Other income for the three months ended December 31, 2020 and 2019 were as follows:
 
 
 
Three Months Ended December 31,
 
 (Unaudited)
 
2020
 
 
2019
 
Interest income
 $30 
  52 
Other rental income
  24 
  30 
Exchange loss
  (93)
  (66)
Dividend income
  30 
  - 
Government grant
  106 
  - 
Other miscellaneous income
  46 
  24 
Total
 $143 
 $40 
 
Other income increased by $103 from $40 to $143 for the three months ended December 31, 2020 compared to the same period in the last fiscal year. The increase was primarily due to the Company receiving government grants of $106 from the local government in the Singapore and Malaysia operations, of which $101 reflects financial assistance to mitigate the negative impact on the businesses amid the pandemic. The increase was partially offset with the increase in unfavorable foreign exchange movement for the three months ended December 31, 2020.
 
Income Tax Expenses
 
The Company's income tax expense was $nil and $120 for the three months ended December 31, 2020 and December 31, 2019, respectively. The decrease of $120 was primarily due to absence of capital gain tax of $94 incurred in the Malaysia operation in the same period in the last fiscal year.
 
Non-controlling Interest
 
As of December 31, 2020, we held a 55% interest in Trio-Tech (Malaysia) Sdn. Bhd., Trio-Tech (Kuala Lumpur) Sdn. Bhd., SHI International Pte. Ltd., and PT. SHI Indonesia. We also held a 76% interest in Prestal Enterprise Sdn. Bhd. The share of net loss from the subsidiaries by the non-controlling interest for the three months ended December 31, 2020 was $184, an increase of $653 compared to the share of net profit from the subsidiaries by the non-controlling interest of $439 for the same period of the previous fiscal year. The increase in the net loss of the non-controlling interest in the subsidiaries was attributable to the increase in net loss generated by the Malaysia operation, coupled with the absence of the gain on sale of assets held for sale which occurred the same period in the previous fiscal year.
 
Net Income Attributable to Trio-Tech International Common Shareholders
 
Net income attributable to Trio-Tech International common shareholders for the three months ended December 31, 2020 was $235, a deterioration of $191, compared to a net income of $426 for the same period last fiscal year.
 
 
 
Earnings per Share
 
Basic earnings per share from continuing operations were $0.06 for the three months ended December 31, 2020 compared to $0.12 for the same period in the last fiscal year. Basic earnings per share from discontinued operations were $nil for both the three months ended December 31, 2020 and 2019.
 
Diluted earnings per share from continuing operations were $0.06 for the three months ended December 31, 2020 as compared to $0.11 for the same period in the last fiscal year. Diluted earnings per share from discontinued operations were $nil for both the three months ended December 31, 2020 and 2019.
 
Segment Information
 
The revenue, gross margin and income or loss from operations for each segment during the second quarter of fiscal year 2021 and fiscal year 2020 are presented below. As the revenue and gross margin for each segment have been discussed in the previous section, only the comparison of income or loss from operations is discussed below.
 
Manufacturing Segment
 
The revenue, gross margin and income / (loss) from operations for the manufacturing segment for the three months ended December 31, 2020 and 2019 were as follows:
 
 
 
Three Months Ended 
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
Revenue
 $3,569 
 $3,045 
Gross margin
  22.4%
  21.7%
Income / (loss) from operations
 $81 
 $(87)
 
Income from operations from the manufacturing segment was $81 compared to a loss from operations of $87 in the same period of the last fiscal year, primarily due to an increase in gross margin of $137 and a decrease in operating expenses of $31. Operating expenses for the manufacturing segment were $718 and $749 for the three months ended December 31, 2020 and 2019, respectively. The decrease in operating expenses was mainly due to a decrease of $6 in general and administrative expenses, $12 in selling expenses, and $13 in corporate overhead expenses. The decrease in general and administrative expenses was mainly attributable to a decrease in payroll-related expenses in the Singapore operations. The decrease in selling expenses was primarily attributable to lower traveling expenses due to the worldwide travel restrictions imposed to contain the spread of the pandemic.
 
Testing Segment
 
The revenue, gross margin and loss from operations for the testing segment for the three months ended December 31, 2020 and 2019 were as follows:
 
 
 
Three Months Ended 
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
Revenue
 $3,560 
 $3,887 
Gross margin
  24.8%
  24.9%
Loss from operations
 $(336)
 $(161)
 
Loss from operations in the testing segment for the three months ended December 31, 2020 was $336, a deterioration of $175 from income from operations of $161 in the same period of the last fiscal year. The deterioration was mainly attributable to a decrease in gross profit, as discussed earlier, and an increase in operating expenses. Operating expenses were $1218 and $1,130 for the three months ended December 31, 2020 and 2019, respectively. The increase of $88 in operating expenses was mainly due to an increase in corporate overhead expenses. The increase in corporate overhead expenses was due to a change in the corporate overhead allocation compared to the same period in the last fiscal year. Corporate charges are allocated on a pre-determined fixed charge basis.
 
 
 
Distribution Segment
 
The revenue, gross margin and income from operations for the distribution segment for the three months ended December 31, 2020 and 2019 were as follows: 
 
 
 
Three Months Ended 
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
Revenue
 $1,065 
 $2,014 
Gross margin
  19.2%
  13.7%
Income from operations
 $120 
 $188 
 
Income from operations was $120 for the three months ended December 31, 2020, compared to $188 for the same period of last fiscal year. The decrease of $68 was mainly due to a decrease of $72 in the gross margin, as discussed earlier. Operating expenses were $84 and $88 for the three months ended December 31, 2020 and 2019, respectively.
 
Real Estate Segment
 
The revenue, gross margin and loss from operations for the real estate segment for the three months ended December 31, 2020 and 2019 were as follows: 
 
 
 
Three Months Ended 
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
Revenue
 $7 
 $16 
Gross margin
  (214.3)%
  (12.5)%
Loss from operations
 $(34)
 $(35)
 
Loss from operations in the real estate segment for the three months ended December 31, 2020 was $34 compared to $35 for the same period of last fiscal year. Operating expenses were $19 and $33 for the three months ended December 31, 2020 and 2019, respectively. The decrease in operating expenses by $14 was mainly due to the absence of bonus expense for the three months ended December 31, 2020, compared to the bonus expense in the same period of prior last fiscal year.
 
Corporate
 
The income / (loss) from operations for Corporate for the three months ended December 31, 2020 and 2019 was as follows:   
 
 
 
Three Months Ended 
December 31,
 
(Unaudited)
 
2020
 
 
2019
 
Income / (Loss) from operations
 $132 
 $(78
 
Corporate operating income was $132 for the three months ended December 31, 2020, an increase of $210 from the corporate operating loss of $78 in the same period of the last fiscal year. The increase was mainly attributable to a change in the corporate overhead allocation as compared to the same period last fiscal year. Corporate charges are allocated on a pre-determined fixed charge basis.
 
 
 
Comparison of the Six Months Ended December 31, 2020 and December 31, 2019
 
The following table sets forth certain consolidated statements of income data as a percentage of revenue for the six months ended December 31, 2020 and 2019, respectively:
 
 
 
Six Months Ended
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
 
 
 
 
 
 
 
Revenue
  100.0%
  100.0%
Cost of sales
  77.5 
  77.9 
Gross Margin
  22.5%
  22.1%
Operating expenses:
    
    
General and administrative
  22.1%
  19.0%
Selling
  1.5 
  1.9 
Research and development
  1.3 
  1.0 
Gain on disposal of plant and equipment
  - 
  (0.1)
Total operating expenses
  24.9%
  21.8%
(Loss)/ Income from Operations
  (2.4)%
  0.3%
 
Overall Gross Margin
 
Overall gross margin as a percentage of revenue remained comparable at 22.5% for the six months ended December 31, 2020, compared to 22.1% in the same period of last fiscal year. In terms of absolute dollar amounts, gross profits decreased by $769 to $3,388 for the six months ended December 31, 2020 from $4,157 for the same period of the last fiscal year.
 
Gross profit margin as a percentage of revenue in the manufacturing segment increased by 1.6% to 24.0% for the six months ended December 31, 2020, from 22.4% in the same period of the last fiscal year. In absolute dollar amounts, gross profit increased by $63 to $1,487 for the six months ended December 31, 2020 compared to $1,424 for the same period in the last fiscal year. The gross margin increase as a percentage of revenue was primarily because the orders in the second quarter of fiscal 2021 had a higher margin than those in the same period of the prior fiscal year.
 
Gross profit margin as a percentage of revenue in the testing segment decreased by 3.0% to 23.2% for the six months ended December 31, 2020 from 26.2% in the same period of the last fiscal year.  There was a further deterioration in testing revenue in the Malaysia and China operations where significant portions of our cost of goods sold are fixed. As the demand for services and factory utilization decrease, the fixed costs are spread over the decreased output, which decreases the gross profit margin. However, this negative impact was partially mitigated by management’s efforts at reducing costs in the China operations. In terms of absolute dollar amounts, gross profit in the testing segment decreased by $654 to $1,514 for the six months ended December 31, 2020, from $2,168 for the same period of the last fiscal year.
 
Gross profit margin as a percentage of revenue in the distribution segment increased by 4.1% to 17.9% for the six months ended December 31, 2020, from 13.8% in the same period of the last fiscal year. In terms of absolute dollar amounts, gross profit in the distribution segment for the six months ended December 31, 2020 was $415, a decrease of $153 compared to $568 in the same period of the last fiscal year. The decrease in the absolute dollar amount of gross margin resulted from a decrease in distribution revenue in the Singapore operation. The gross profit margin of the distribution segment was affected not only by the market price of our products but also by our product mix, which frequently changes due to fluctuations in market demand.
 
Gross loss margin as a percentage of revenue in the real estate segment increased by 245.4% to 254.5% for the six months ended December 31, 2020, from 9.1% in the same period of the last fiscal year. In terms of absolute dollar amounts, gross loss increased by $25 to $28 for the six months ended December 31, 2020 compared to $3 for the same period in the last fiscal year. The increase in gross loss mainly resulted from a decrease in rental income amid the pandemic.
 

 
Operating Expenses
 
Operating expenses for the six months ended December 31, 2020 and 2019 were as follows:
 
 
Six Months Ended
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
General and administrative
 $3,322 
 $3,565 
Selling
  233 
  366 
Research and development
  198 
  201 
Gain on disposal of plant and equipment
  (1)
  (24)
Total
 $3,752 
 $4,108 
 
General and administrative expenses decreased by $243, or 6.8%, from $3,565 to $3,322 for the six months ended December 31, 2020 compared to the same period of the last fiscal year. The decrease in general and administrative expenses was primarily due to the lower payroll and staff-related expenses in the Singapore, Malaysia, and China operations. In addition, there was also a decrease in doubtful debts provision in the six months ended December 31, 2020 compared to the same period of the prior fiscal year.
 
Selling expenses decreased by $133, or 36.3%, for the six months ended December 31, 2019, from $366 to $233 compared to the same period of the last fiscal year. The decrease in selling expenses was primarily attributable to lower traveling expenses due to the worldwide travel restrictions imposed to contain the spread of the pandemic.
 
(Loss) / Income from Operations
 
Loss from operations was $364 for the six months ended December 31, 2020 compared to income from operations of $49 for the same period of the last fiscal year. The decrease was mainly due to the decrease in gross profit margin, offset with a decrease in operating expenses, as discussed earlier.
 
Interest Expense
 
Interest expense for the six months ended December 31, 2020 and 2019 were as follows:
 
 
Six Months Ended
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Interest expense
 $71 
 $123 
 
Interest expense decreased by $52 to $71 from $123 for the six months ended December 31, 2020 compared to the same period of the last fiscal year. The decrease was mainly due to lower utilization of lines of credit in the Singapore operations. Additionally, the bank loan payables decreased by $136 to $2,342 for the six months ended December 31, 2020 compared to $2,206 as of June 30, 2020.
 
Other Income
 
Other income for the six months ended December 31, 2020 and 2019 was as follows:
 
 
Six Months Ended
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Interest income
 $70 
 $84 
Other rental income
  45 
  60 
Exchange loss
  (137)
  (61)
Bad debt recovery
  - 
  11 
Dividend Income
  32 
  - 
Government grant
  260 
  - 
Other miscellaneous income
  84 
  56 
Total
 $354 
 $150 
 
 
 
Other income for the six months ended December 31, 2020 was $354, an increase of $204 compared to $150 for the same period of last fiscal year. The increase was primarily due to the Company receiving government grants of $260 from the local governments in the Singapore and Malaysia operations, of which $243 reflects financial assistance to mitigate the negative impact on the businesses amid the pandemic. The increase was partially offset with the unfavorable foreign exchange movement for the six months ended December 31, 2020.
 
Income Tax Expenses
 
Income tax expenses for the six months ended December 31, 2020 was $7, a decrease of $113 compared to $120 for the same period last fiscal year. The decrease in income tax expense was primarily due to absence of the capital gain tax from the sale of asset held for sale in the Malaysia operation in the six months ended December 31, 2020.
 
Non-controlling Interest
 
As of December 31, 2020, we held a 55% interest in Trio-Tech Malaysia, Trio-Tech (Kuala Lumpur) Sdn. Bhd., SHI International Pte. Ltd. and PTSHI Indonesia, and a 76% interest in Prestal Enterprise Sdn. Bhd. The net loss attributable to the non-controlling interest in these subsidiaries for the six months ended December 31, 2020 was $342, a deterioration of $771, compared to a net income of $429 for the same period of last fiscal year. The deterioration was attributable to the absence of gain from the sale of asset held for sale by the Malaysia operation in the six months ended December 31, 2020.
 
Net Income Attributable to Trio-Tech International Common Shareholders
 
Net income was $227 for the six months ended December 31, 2020, a decrease of $472 compared to a net income of $699 for the same period in the last fiscal year. The decrease was mainly due to the decrease in revenue and gross margin, coupled with the absence of the gain on the sale of asset held for sale in the Malaysia operation. However, the decrease was partially offset with a decrease in operating expenses, as discussed earlier.
 
Earnings per Share
 
Basic earnings per share from continuing operations was $0.06 for the six months ended December 31, 2020 compared to $0.19 for the same period in the last fiscal year. Basic earnings per share from discontinued operations were nil for both the six months ended December 31, 2020 and 2019.
 
Diluted earnings per share from continuing operations was $0.06 for the six months ended December 31, 2020 compared to $0.19 for the same period in the last fiscal year. Diluted earnings per share from discontinued operations were nil for both the six months ended December 31, 2020 and 2019.
 
Segment Information
 
The revenue, gross profit margin, and income or loss from operations in each segment for the six months ended December 31, 2020 and 2019, respectively, are presented below. As the segment revenue and gross margin for each segment have been discussed in the previous section, only the comparison of income / (loss) from operations is discussed below.
 
Manufacturing Segment
 
The revenue, gross margin and income / (loss) from operations for the manufacturing segment for the six months ended December 31, 2020 and 2019 were as follows:
 
 
Six Months Ended
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Revenue
 $6,194 
 $6,362 
Gross margin
  24.0%
  22.4%
Income / (Loss) from operations
 $63 
 $(99)
 
Income from operations from the manufacturing segment was $63 for the six months ended December 31, 2020, a change of $162 as compared to a loss from operations of $99 in the same period of the last fiscal year due to an increase in gross margin and a decrease in operating expenses. The manufacturing segment's operating expenses were $1,424 and $1,523 for the six months ended December 31, 2020 and 2019, respectively. The decrease in operating expenses of $99 was mainly due to a decrease in general and administrative expenses by $30, a decrease in selling expenses by $51, and a decrease in corporate overhead by $18 compared to the same period of last fiscal year. The decrease in general and administrative expenses was mainly attributable to a decrease in payroll-related expenses and the absence of a provision of doubtful debt in the Singapore operations. The decrease in selling expenses was primarily due to traveling expenses incurred for the six months ended December 31, 2020, as there is a worldwide travel restriction to contain the spread of the pandemic.
 
 
 
Testing Segment
 
The revenue, gross margin and loss from operations for the testing segment for the six months ended December 31, 2020 and 2019 were as follows:
 
 
 
Six Months Ended 
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Revenue
 $6,514 
 $8,277 
Gross margin
  23.2%
  26.2%
Loss from operations
 $(673)
 $(93)
 
Loss from operations in the testing segment for the six months ended December 31, 2020 was $673, a deterioration of $580 compared to $93 in the same period of the last fiscal year. The decrease in gross margin of $654 offset with a decrease in operating expenses of $74, also contributable to the increase in operating loss. Operating expenses were $2,187 and $2,261 for the six months ended December 31, 2020 and 2019, respectively. The lower operating expenses were mainly attributed to a decrease in general and administrative expenses and selling expenses by $227 and $71, respectively. The decrease offset with an increase in corporate overheads by $204 and a decrease in the gain from the sales of property, plant and equipment by $23. The decrease in general and administrative expenses was due to a decrease in payroll-related expenses in the Malaysia and China operations as part of our cost-savings measures. The increase in corporate overhead expenses was due to a change in the corporate overhead allocation compared to the same period last fiscal year. Corporate charges are allocated on a pre-determined fixed charge basis.
 
Distribution Segment
 
The revenue, gross margin and income from operations for the distribution segment for the six months ended December 31, 2020 and 2019 were as follows: 
 
 
Six Months Ended 
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Revenue
 $2,323 
 $4,113 
Gross margin
  17.9%
  13.8%
Income from operations
 $244 
 $392 
 
Income from operations in the distribution segment for the six months ended December 31, 2020 was $244, a decrease of $148 compared to $392 in the same period of the last fiscal year. The decrease in operating income was primarily due to a decrease in gross margin by $153, which was partially offset with a decrease in operating expenses of $5. Operating expenses were $171 and $176 for the six months ended December 31, 2020 and 2019, respectively.
 
Real Estate Segment
 
The revenue, gross loss margin and loss from operations for the real estate segment for the six months ended December 31, 2020 and 2019 were as follows: 
 
 
 
Six Months Ended 
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Revenue
 $11 
 $33 
Gross loss margin
  254.5%
  9.1%
Loss from operations
 $(61)
 $(52)
 
Loss from operations in the real estate segment for the six months ended December 31, 2020 was $61, a further deterioration of $9 compared to $52 for the same period of the last fiscal year. The increase in operating loss was mainly due to an increase in gross loss margin, as discussed earlier. Operating expenses were $33 and $49 for the six months ended December 31, 2020 and 2019, respectively. The decrease in operating expenses was mainly due to the absence of one-off payroll-related expenses, which occurred in the same period of the prior fiscal year.
 
 
 
Corporate
 
The income / (loss) from operations for corporate for the six months ended December 31, 2020 and 2019 were as follows:   
 
 
 
Six Months Ended
 
 
 
Dec. 31,
2020
 
 
Dec. 31,
2019
 
(Unaudited)
 
 
 
 
 
 
Income / (loss) from operations
 $63 
 $(99)  
 
The improvement of $162 was mainly due to a change in the corporate overhead allocation as compared to the same period last fiscal year. Corporate charges are allocated on a pre-determined fixed charge basis.
 
Financial Condition
 
During the six months ended December 31, 2020 total assets increased by $2,703 to $38,363 compared to $35,660 as of June 30, 2020. The increase in total assets was primarily due to an increase in cash and cash equivalents, short-term deposits, trade account receivables, inventories, prepaid expenses and other current assets, deferred tax assets, investment properties, operating lease right-of-use, other assets and restricted term deposits. This was partially offset by a decrease in other receivables, and property, plant and equipment.
 
Cash and cash equivalents were $4,470 as at December 31, 2020, reflecting an increase of $320 from $4,150 as at June 30, 2020, primarily due to the Company generated operating cash flow of $301 for the six months ended December 31, 2020.
 
Short-term deposits were $6,940 as at December 31, 2020, reflecting a decrease of $102 from $6,838 as at June 30, 2020. The increase was primarily due to an increase in deposits in the Singapore operation.

As at December 31, 2020, the trade accounts receivable balance increased by $1,630 to $7,581, from $5,951 as at June 30, 2020, primarily due to the increase in revenue in the Malaysia, China, and U.S. operations. This increase was partially offset by the decrease in the Thailand operations. The number of days’ sales outstanding in accounts receivables for the Group was 88 and 67 days at the end of the second quarter of the fiscal year 2021 and the end of the last fiscal year, respectively.
 
As at December 31, 2020 other receivables were $670, reflecting a decrease of $328 from $998 as at June 30, 2020. The decrease was primarily due to a decrease in advance payments made to suppliers in the Singapore operation.
 
Inventories as at December 31, 2020 were $2,147, an increase of $225, compared to $1,922 as at June 30, 2020. The increase in inventories was in line with an increase in orders by customers in the manufacturing segment of the Singapore and U.S. operations.
 
Prepaid expenses and other current assets were $342 as at December 31, 2020 compared to $341 as at June 30, 2020.
 
Investment properties’ net in China was $712 as at December 31, 2020 and $690 as at June 30, 2020. The increase was primarily due to the foreign currency exchange movement between June 30, 2020 and December 31, 2020. The increase was partially offset by the depreciation charged for the period. 
 
Property, plant and equipment decreased by $260 from $10,310 as at June 30, 2020, to $10,050 as at December 31, 2020, mainly due to depreciation charged for the period and the foreign currency exchange movement between June 30, 2020 and December 31, 2020. The decrease was partially offset by the new property, plant, and equipment acquisition in the Singapore and Malaysia operations.
 
Restricted term deposits increased by $92 to $1,752 as at December 31, 2020 as compared to $1,660 as at June 30, 2020. This was primarily due to the foreign currency exchange movement between June 30, 2020 and December 31, 2020.
 
Other assets increased by $222 to $1,831 as at December 31, 2020 compared to $1,609 as at June 30, 2020.  This was mainly due to down payments made for the purchase of equipment in the Malaysia operation.
 
Lines of credit decreased by $172 to $nil as at December 31, 2020 as compared to $172 as at June 30, 2020. This was due to lower utilization of the bank facilities in the Singapore operation.
 
 
 
Accounts payable increased by $513 to $3,103 as at December 31, 2020 as compared to $2,590 as at June 30, 2020. This was due to an increase in sales, which lead to more materials purchased to meet customer requirements in the Singapore operation.
 
Accrued expenses increased by $390 to $3,395 as at December 31, 2020 as compared to $3,005 as at June 30, 2020. The increase in accrued expenses was mainly due to an increase in the accrued purchases in the Singapore operation.
 
Bank loans payable increased by $136 to $2,342 as at December 31, 2020 as compared to $2,206 as at June 30, 2020. This was due to the additional loan drawdown in the Malaysia operation.
 
Finance leases decreased by $86 to $580 as at December 31, 2020 as compared to $666 as at June 30, 2020. This was due to the repayments made in the Malaysia operation.
 
Operating lease right-of-use assets and the corresponding lease liability increased by $570 to $1,514 as of December 31, 2020, as compared to $944 as at June 30, 2020. This was due to the renewal of the lease agreements in the Singapore operations. The increase was partially offset with the repayment made and the operating lease expenses charged for the period.
 
As of December 31, 2020 and June 30, 2020, the Company accounted $121 for the Paycheck Protection Program which was created by the United States Coronavirus Aid, Relief, and Economic Security (CARES) Act.
 
Liquidity Comparison
 
Net cash provided by operating activities decreased by $1,258 to an inflow of $315 for the six months ended December 31, 2020 from an inflow of $1,573 for the same period of the last fiscal year. The decrease in net cash inflow provided by operating activities was primarily due to a decrease in net income by $1,243 and an increase in cash outflow of $1,727 from trade accounts receivable. These increases were partially offset by a decrease in depreciation and amortization amounted to $107 and an increase in cash inflow of $1,006 from accounts payables and accrued expenses.
 
Net cash used investing activities decreased by $2,010 to an outflow of $106 for the six months ended December 31, 2020 from an outflow of $2,116 for the same period of the last fiscal year. The decrease in cash outflow was primarily due to a decrease in investment in unrestricted term deposits by $2,263 and $527 in capital expenditures, coupled with an increase in cash inflow of $520 from the withdrawal of unrestricted deposit. These decreases were partially offset by a decrease in cash inflow of $1,261 from proceed from sale of asset held for sale.
 
Net cash used in financing activities for the six months ended December 31, 2020 was $357, representing a decrease of $752, as compared to cash inflow $395 during the six months ended December 31, 2019. The increase in cash outflow was mainly attributable to a decrease in cash inflow by $1,337 from the lines of credit proceeds. This increase was partially offset by a decrease in cash outflow of $555 from the payments on lines of credit.
 
Critical Accounting Estimates & Policies
 
Effective as of July 1, 2019, the Company has adopted ASU 2016-02, Leases (Topic 842), and its related amendments using the modified retrospective transition method. We have completed our adoption and implemented policies, processes and controls to support the standard’s measurement and disclosure requirements as described in note 1 to the financial statements included in item 1 of this Form 10-Q.
 
 
 
ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Not applicable.
 
ITEM 4.  CONTROLS AND PROCEDURES
 
An evaluation was carried out by the Company’s Chief Executive Officer and Chief Financial Officer of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2020, the end of the period covered by this Form 10-Q. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective at a reasonable level.  
 
Changes in Internal Control Over Financial Reporting
 
Except as discussed below, there has been no change in the Company’s internal control over financial reporting during the fiscal quarter ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
Enterprise Resource Planning (ERP) Implementation
 
We are in the process of implementing an ERP System as part of a multi-year plan to integrate and upgrade our systems and processes. The implementation of this ERP system was scheduled to occur in phases over a few years. The operational and financial systems in our Singapore and Malaysia operations were transitioned to the new system in fiscal 2018 and fiscal 2019, respectively.
 
The operational and financial systems in our Tianjin and Suzhou operations have been fully transitioned to the new system during the second quarter of fiscal 2021. This implementation effort will continue until the Group's consolidation process is substantially automated using the new system.
 
As a phased implementation of this system occurs, we are experiencing certain changes to our processes and procedures which, in turn, result in changes to our internal control over financial reporting. While we expect the new ERP system to strengthen our internal financial controls by automating certain manual processes and standardizing business processes and reporting across our organization, management will continue to evaluate and monitor our internal controls as processes and procedures in each of the affected areas evolve.
 
 
 
TRIO-TECH INTERNATIONAL
PART II. OTHER INFORMATION
 
Item 1.          Legal Proceedings
 
Not applicable.
 
Item 1A.       Risk Factors
 
Not applicable
 
Item 2.          Unregistered Sales of Equity Securities and Use of Proceeds
 
Malaysia and Singapore regulations prohibit the payment of dividends if the Company does not have sufficient retained earnings and tax credit. In addition, the payment of dividends can only be made after making deductions for income tax pursuant to the regulations. Furthermore, the cash movements from the Company’s 55% owned Malaysian subsidiary to overseas are restricted and must be authorized by the Central Bank of Malaysia. California law also prohibits the payment of dividends if the Company does not have sufficient retained earnings or cannot meet certain asset to liability ratios.
 
Item 3.          Defaults Upon Senior Securities
 
Not applicable.
 
Item 4.          Mine Safety Disclosures
 
Not applicable.
 
Item 5.          Other Information
 
Not applicable.
 
Item 6.          Exhibits
 
 Rule 13a-14(a) Certification of Principal Executive Officer of Registrant
 Rule 13a-14(a) Certification of Principal Financial Officer of Registrant 
 Section 1350 Certification
   
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema
101.CAL XBRL Taxonomy Extension Calculation Linkbase
101.DEF XBRL Taxonomy Extension Definition Linkbase
101.LAB XBRL Taxonomy Extension Label Linkbase
101.PRE XBRL Taxonomy Extension Presentation Linkbase
  
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.                   
                                          
 
 
TRIO-TECH INTERNATIONAL
 
 By:
/s/ Victor H.M. Ting
VICTOR H.M. TING
Vice President and Chief Financial Officer
(Principal Financial Officer)
Dated: February 11, 2021
 
 

 
 
 
 
-49-